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Chapter Ⅰ 
General Introduction 
 
Food safety is very important for our social life. Once they were threaten, 
we would not live normal social life. In order to prevent threat, several ways of 
approaching this problem are required. For example, we have to reduce 
“foodborne-incidents” with infected invisible things such as virus and 
micro-organism by proper way based on science technology such as bacteriology. 
Figure 1 shows the number of foodborne-illness incidents in Japan (Japanese 
Government Bulletin). The biggest number of them is origin from bacteria, 
indicating that safety measures against this origin is most important. 
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Figure 2 The number of Foodborne incidents on several year 
(Health, Labour and Welfare Ministry of Japan HP) 
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Figure 1    The Number of Foodborne Incidents 
                   (2010 Japanese Government Bulletin HP ) 
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Most of foodborne-incidents by bacteria comes from Salmonella, 
pathogenic E. coli such as O-157, Campylobacter and Vibrio.  Figure 2 shows 
the number of incidents for foodborne-incidents from bacteria on recent years in 
Japan (Ministry of Health, Labor and Welfare, Japan HP, 2013). The number 
from Campylobacter is biggest one, and next one is from Salmonella. However, 
Salmonella incident is the most popular foodborne incident in the USA (Figure 
3, Centers for Disease Control and Prevention). These observations suggest 
that adequate measures should be taken to prevent Salmonella incident 
worldwide. 
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Figure 3  The number of Foodborne incidents on several year 
(CDC in USA) 
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Table 1, which shows bacteria infection of  several foods in 2010, indicates 
that most of Salmonella infection comes from animal foods, especially in 
chicken. Host domestic animals are, in many case, infected during feeding 
period in a farm, and then they were tranfered to slaughter house and meat 
processing center with a bactreia. Sometimes  contamination of meat occurred 
in the house and center,  and then the contamination is increased by touching 
each other. To prevent the infection of pathogenic these bacterias from a 
stockbreeding, in general, three principles are proposed in a farm: “No 
invasion”, “No propagating”, and “No carrying out” . No invasion means that no 
contaminated feed with bacteria and no host animal such as mice in a farm. No 
propagating means that once some bactreria invase to a farm, no propagating 
will be done untill it become hamful for human. No carrying out means no 
carrying infected animal out from a farm. Thus, antibiotics have been applied 
widely in the human and domestic animal. In feed antibiotics have been used 
with the aim of not only curing infected animals but also promoting growth of 
animals. However, recently it is getting bigger that social issue for appearing 
drug-resistance strain of bacteria on several antibiotics. For example, NARMS 
(National Antimicrobial Resistance Monitoring System) Retail Meat Annual 
Report 2011 showed that 69% of pork chop, 55% of ground beef, 39% of chicken 
Table 1 Bacteria infection of several foods that are designated by Wefare Ministry of Japan(2011)
(Health, Labour and Welfare Ministry of Japan HP)

Product name Products No.
E. coli Salmonella Pathogenic E. coli Campylobacter
Vegetable Alfalfa 13 3 - - -
Radish Sprouts 91 15 - - -
Cutting Vegetable 150 12 - - -
Cucumber 112 7 - - -
Mitstba 58 20 1 - -
Sprout 103 41 - - -
Lettuce 103 12 - - -
Vegetable Pickles 158 16 - - -
Meat Mince(Cow) 102 67 3 - -
Mince(Swine) 144 99 2 - -
Mince(Mixed) 103 72 3 - -
Mince(Chicken) 159 127 88 - 60
Cow Lever(be cooked) 225 159 2 - 34
Steak Meat(cutting) 52 21 - - -
Seared Beaf 13 3 - - -
Seared Chicken 33 29 1 - 4
Horse Sashimi 78 8 - - -
Loasted Beaf 108 3 - - -
Total 1805 714 100 0 98
Results(Negative No.)
４ 
breast and 81% of ground turkey had a drug resitance strain of bacteria. 
Salmonella and Campylobacter were found so many there. The Pew Charitable 
Trusts reported on their web site that sold antibiotics for animals in 2010 is 
more than 13,000 ton, and one for human is only about 3,500 ton in USA (Pew 
Charitable Trusts). European community banned using all antibiotics for 
animal feeding as purpose of growth promoting on 2005 (Dibner and Richard, 
2005), and FDA ban using some antibiotics as same purpose as well (Ohshima, 
2006). From above social situation, most important thing is to find out an 
effective and safety material alternative to antibiotics. 
Mannose and mannose-based oligosaccharides have been extensively 
explored in poultry because of its inhibitory properties to the FimH adhesins 
present in enteric salmonellas (Fernandez et al., 2002; Oyofo et al., 1989a; 
Oyofo et al., 1989b). Particularly mannose has more active-point to adhere with 
Salmonella comparing to Mannose-based oligosaccharides. However, mannose 
is very unstable in the intestine when compared to mannobiose. because it is 
degraded faster by intestinal bacterial flora than β1,4 mannobiose (MNB) 
which is coming from mannanase hydrolyzed copra meal (MCM). (Morikoshi et 
al. 2003). Therefore it is possible that MNB and MCM can be used as an 
alternative to antibiotics.  
 
The structure of MNB is shown on Figure 4. MNB, one of the 
disaccharides, has an interesting structure: upper side is like a hydrophilic and 
under side like a hydrophobic. 
Figure 4   Structure of MNB 
 
 
５ 
The flow chart of production of MCM is on Figure 5. Copra Meal (CM), 
de-fated or expellered coconuts as the by-product of oil, is generally granule 
powder form. Typical composition of CM is shown in Table 2. It contains about 
20% of crude protein, 12% of crude fat, and 30% of mannan as raw material of 
MNB. MNB is produced from CM by mannanase treatment. The author 
designed the MCM including MNB as “MCM-B1” (11.4% MNB), “MCM-B2” 
(67.8% MNB), and  “MNB” ( 99% MNB) 
The aim of this study is that the the evaluation of  the natural feed 
ingredients MNB and MCM as alternatives of antibiotics or growth promoters 
in poultry industry.  
 
 
 
 
 
 
 
 
 
 
 
 
Table2  Typical Content of Copra meal(%)
Crude Protein 20
Crude Fat 12
Crude fiber 8
Ash 6
Moisture 6
Glucide 18
Mannan 30
６ 
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Chapter Ⅱ 
Effect of dietary β1,4 mannobiose (MNB) in the prevention of Salmonella 
enteritidis infection in broilers 
 
Introduction 
Salmonella enterica serovar Enteritidis (SE) is widely distributed in 
commercial chicken flocks and high levels of cecal carriage and shedding may 
lead to broiler meat contamination. Recently, chicken consumption is a newly 
identified risk factor in SE infection in humans (Kimura et al., 2004).  The 
uses of oligosaccharides in domestic animal species including horses (Spearman, 
2004), dairy cattle (Franklin et al., 2005), pigs (LeMieux et al., 2003) and 
poultry (Fernandez et al., 2002) have been very popular in the last decade.  In 
human research, oligosaccharides gained a significant level of interest because 
of its potential impact on nutritional immunology (Watzl et al., 2005).  A 
number of different oligosaccharides have emerged with variable effects in the 
general health and immune response to pathogens in both humans and animals.  
In poultry, oligosaccharides have been well documented as an alternative to 
antimicrobials in the reduction of SE, a major causative agent in enteritis 
outbreaks associated with the consumption of SE-contaminated broiler meats. 
A range of oligosaccharides is used as “prebiotics” in both humans and 
animals.  These are “non-digestible food ingredient that beneficially affects the 
host by selectively stimulating the growth and/or activity of one or a limited 
number of bacteria in the colon” (Gibson and Roberfroid, 1995; Gibson et al., 
1995).  These carbohydrates are basically derived from various plants sources 
and can resist hydrolysis and digestion in the upper gastrointestinal tract but 
are hydrolyzed and fermented in the large intestines (Delzenne, 2003).  Some 
of the oligosaccharide evaluated in food animals include: 
fructose-oligosaccharides (Chambers et al., 1997; Bailey et al., 1991), 
galactose-oligosaccharides (Smiricky-Tjardes et al., 2003a), 
sucrose-oligosaccharides (Orban et al., 1997a; Orban et al., 1997b), 
isomalto-oligosaccharides (Chung and Day, 2004), and mannan- 
８ 
oligosaccharides (Franklin et al., 2005; Spearman, 2004).  Oligosaccharides 
are used alone or sometimes in combination with probiotics (Fukata et al., 
1999), growth promoting antimicrobials (Sims et al., 2004; Parks et al., 2001), 
polyunsaturated fatty acids (Bomba et al., 2003), and micronutrients (David et 
al., 2002).  
A review of various animal studies suggests that continuous feeding of 
oligosaccharides can result to an increased production of short chain fatty acids 
(SCFA) such as acetate, lactate, propionate, and butyrate, leading to 
proliferation of beneficial bacteria such as Bifidobacterium and Lactobacillus 
(Delzenne, 2003) in the distal intestines.  A substantial population of 
Bifidobacterium and Lactobacillus is required for the formation of mucosal 
biofilm, which serves as a barrier in the gut mucosa against pathogenic insults 
(Kleessen and Blaut, 2005).  It has been demonstrated that oligosaccharides, 
regardless of its chain length are readily fermentable but varied in amount and 
type of SCFA produced (Smiricky-Tjardes et al., 2003b). 
Mannose-containing oligosaccharide (MOS, mannanoligosaccharide) is 
one of the most popular and commercially available prebiotics for poultry use 
(Ferket, 2004).  MOS exerts various health benefits in two of the economically 
important food animal species – poultry and swine.  MOS depresses the 
proliferation of Clostridium perfringens, the causative agent of necrotic 
enteritis in broilers which remains as the most important Gram-positive 
bacterium in intensive commercial broiler operations following the banning of 
antimicrobial growth promotants (Denev et al., 2005).  In birds vaccinated 
with Infectious Bursal Disease (Gumboro) and Newcastle Disease Virus (NDV, 
Fowl plague), the feeding of MOS improves the vaccinal response, improving 
the resistance of birds to field challenge with these pathogens.  The nutritional 
status of the bird is also influenced by the addition of MOS in the diet, 
exemplified by morphological changes in the intestinal villi increasing the 
surface area for nutrient resorption.  In the presence of bacterial (S. 
Typhimurium) and protozoal (Eimeria spp.) organisms, MOS can effectively 
maintain the targeted feed conversion rate (FCR), therefore reducing the 
９ 
impact on performance during a disease challenge (Rios et al., 2005).  In birds 
fed diets contaminated with aflatoxin, MOS can increase adsorption and 
degradation of aflatoxins (Zaghini et al., 2005), therefore reducing liver 
pathology and enteritis.  In breeder flocks, MOS feeding improves production 
efficiency parameters, vaccine response, and; passive transfer of antibodies to 
the progeny (Shashidhara and Devegowda, 2003). 
Mannose and mannose-based oligosaccharides have been extensively 
explored in poultry because of its inhibitory properties to the FimH adhesions 
present in enteric salmonellas (Fernandez et al., 2002; Oyofo et al., 1989a; 
Oyofo et al., 1989b).  MNB is a disaccharide and a potential inhibitor of FimH 
adhesion. Unlike D-Mannose, its specific functional health benefits to both 
humans and animals have not been described.  MNB is found in wood and 
plant seeds (Twaddle et al., 2003) and linkage-specific glycosidases are required 
for its production (Kremnicky et al., 1996).  Potentially useful FimH 
receptor-active manno-oligosaccharides of the α- linkage group have been 
described using enzymes derived from Penicillum citrinum, Aspergillus 
phoenicis, and almond (Maitin et al., 2004). In addition to its potential use as 
an anti-adhesive against poultry pathogens, mannobiose may modulate the 
immune response of birds to SE infection, however, its immunological function 
has not been documented in poultry. 
The objectives of this chapter were 1) to determine if MNB supplemented 
feed is effective in the prevention of SE infection in growing broilers by 
characterization of the kinetics of SE infection within a three-week observation 
time post-challenge, 2) to determine the response of chicken fed with the 
different diets on the secretary IgA, and 3) to be able to correlate the resolution 
of the disease by analyzing histological changes in the cecal mucosa and cecal 
tonsils. 
 
Materials and Methods 
Source of feed additive 
The feed supplements MNB , and D-Mannose derived from copra meal by 
１０ 
enzymatic digestion were provided by Fuji Oil, Ltd. (Osaka, Japan).  The feed 
supplements contains 11.4% MNB.  The other one, on the other hand, contains 
10% D-mannose.  Since mannobiose and mannose are the major components of 
the crude feed additives, these feed supplements shall be designated as 
MCM-B1 (MNB as main component) and MAN (D-mannose as main 
component ), respectively. 
 
Experimental diets 
The supplements were directly mixed in the broiler starter/grower 
crumble formulation resulting to a final mixture of 0.1% MCM-B1 or 0.1% MAN.  
The starter or grower crumble feeds used in this chapter were without 
antibiotics or anticoccidial drug (Table 3).  All feeds used in this chapter were 
prepared at the Arkell Research Station, University of Guelph, Guelph, Ontario.  
The feeds used tested negative to Salmonella spp. 
 
Animals 
One hundred twenty 1-day-old chicks (Ross x Ross) were obtained from a 
local commercial hatchery and were screened for Salmonella spp. by cloacal 
swabbing prior to placement.  Animals were housed at the Animal Isolation 
Unit, University of Guelph, The animal experiment was conducted in 
accordance to the animal care guidelines and with the approval of the Animal 
Care Committee, University of Guelph. 
 
Bacterial culture 
SE PT4 SA992212 resistant to novobiocin, a gift from Dr. Cornelius Poppe 
(Health Canada) and originally isolated from chickens was used in this chapter.  
The bacterial culture was retrieved from a bacterial stock and grown in Brain 
Heart Infusion Agar (BD Diagnostic System, Oakville, ON, Canada) overnight 
at 37 ℃ with shaking.  The overnight culture was adjusted to the desired 
colony forming units (CFU) per ml by calorimetric technique (Biomerìeux Vitek, 
Inc. Hazelwood, MO, USA) and confirmed by plating on Brilliant Green Agar 
１１ 
(BGA, BD Diagnostic System, Oakville, ON, Canada).  The methods described 
in the FDA Bacteriological Analytical Manual (Wallace et al. 1995) were used to 
confirm SE. 
 
Table 3  Nutrient compositions of the different diets.   
Ingredients   Starter          Grower   Finisher 
    (g/kg)    (g/kg)    (g/kg) 
Corn    494.3    596.4    638.3 
Soymeal Hi-Pro   276.7    276.0    229.0 
Wheat     75.0     75.0     75.0 
Shorts/wheat Midds   58.9      ‐      ‐ 
Canola meal    50.0      ‐      ‐      
Dicalcium phosphate   16.2              12.5       10.3 
Calcium carbonate   14.9     14.6     13.3  
Fat       ‐              12.7     21.1 
Pellet binder     6.3     6.3      6.3 
Salt      4.1            4.2      4.2 
Liquid methionine (MHA)   1.8      1.6      1.2 
Broiler trace mineral ultra   1.0      ‐             0.5  
Liquid choline chloride    0.8      0.6      0.4 
Lysine pure     ‐      0.1      0.4 
Total          1000.0   1000.0          1000.0 
Note: The regular diet contained all the listed ingredients. The treatment diets contained 
all these plus 0.1% (w/w) MCM-B1 or MAN. 
 
Animal experiments 
In this trial, the purpose of feeding MCM-B1 and MAN during the first 
two weeks of the growing period was to determine if a 2-week feeding can 
reduce the susceptibility of growing birds until they are marketed.  Three 
groups of 20 chicks were placed in wire cages with unlimited access to feed and 
water.  Treatment diets were fed for 2 weeks.  Prior to inoculation, feeds and 
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water were withdrawn overnight.  After this period, birds were then orally 
inoculated with 2 x 107 cfu/ml of SE.   SE fecal shedding was monitored by 
faecal collection and culture every two days starting on the first day up to 19 
days post-infection (p.i.).  Post mortem was conducted in 3 to 5 birds per group 
prior to infection, and at days 1, 7, 14 and 23 days p.i.  Various organs were 
collected for SE enumeration.  The ceca and cecal tonsils were selected for 
histopathological examination. Bile and cecal contents were collected for 
SE-specific IgA assay. 
 
Bacterial count 
Overnight faecal droppings were collected in sterilized aluminum foil (12 
x 12”) randomly placed in three different locations in trays underneath the wire 
flooring and aliquoted for the different bacteriological enumeration. Twenty 
five grams of faeces from each collection site was mixed with 225 ml of 
tetrathionate brilliant green (TBG, BD Diagnostic Systems, Oakville, ON, 
Canada) broth supplemented with 0.02 μg/ml novobiocin (BD Diagnostic 
Systems, Oakville, ON, Canada) and thoroughly mixed in a kitchen blender 
(Osterizer®) for 5 minutes.  Samples were incubated overnight at 41 ℃.   
Cultures were serially diluted 1:10 from 102 to 107 in 1% buffered peptone 
water (BD Diagnostic Systems, Oakville, ON, Canada) and plated in duplicates 
on BGA with 20 mg of novobiocin.   Plates were incubated aerobically at 37 ℃ 
overnight.  For bacterial enumeration in liver, spleen and cecal contents, 
pre-weighed 10 ml culture tubes (Simport®, Fisher Scientific, Neopan, ON, 
Canada) were used to collect samples during necropsy, stored on ice, 9 parts 
TBG with novobiocin added, and homogenized for one minute using Polytron® 
homogenizer (Brinkman Instruments, Inc., Missisauga, ON, Canada).  For the 
enumeration of SE from samples of the cecal wall, samples were suspended in 
10 ml of phosphate buffered saline (PBS, Gibco®, Invitrogen Canada Inc., 
Burlington, ON, Canada), stored on ice and washed 3x with PBS for removal of 
adherent bacteria and debris prior to homogenization.  Succeeding incubation 
steps were similar to the procedure described for the enumeration of feces, but 
１３ 
Salmonella Shigella Agar (SS Agar, BD Diagnostic Systems, Oakville, ON, 
Canada) was used instead of BGA for plating. 
 
Enzyme-linked immunosorbent assay 
Bile, and cecal contents were analyzed for SE-specific IgA antibodies 
using SE whole cell antigen. For antigen preparation, bacterial stock previously 
stored at -80 ℃ in 20% glycerol was thawed and a loopful was plated on BGA.  
After an overnight incubation at 37 ℃, a colony was inoculated in 500 ml of 
BHI and incubated at 37 ℃ for 18 hours with shaking.  The broth culture was 
centrifuged at 2,500 x g at 4 ℃  for 5 minutes.  The supernatant was 
discarded and the pellet was washed 3 times with ice-cold PBS.  The pellet 
was inactivated with 3.8% buffered formalin overnight at room temperature.   
After inactivation, the pellet was harvested by centrifugation and washed 3 
times with ice-cold Milli-Q water to remove the formalin.  The final pellet was 
frozen overnight at -80 ℃ and freeze dried for 24 hours.  The SE whole cells 
were used as a coating antigen. 
For bile collection, the liver was removed and the bile was aseptically 
aspirated from the gall bladder using a 3 ml syringe with gauge 18 needle.  
For cecal contents, the left side of the ceca was squeezed from the distal blunt 
end to the proximal end and was incised above the cecal tonsils.  
Approximately 0.5 to 1 g of the cecal content was placed in pre-weighed sterile 2 
ml microcentrifuge tubes.  The contents were weighed and added with an 
equal amount (1:1) of complete™ Protease Inhibitor Cocktail Tablet (Roche 
Diagnostics Canada), diluted according to manufacturer’s suggestions.  The 
bile and cecal samples were stored as above until use.  Test samples were 
thawed at room temperature and diluted to 1:100 with Tris Buffered Saline 
(TBS) with 1% Bovine Serum Albumin (BSA) prior to analyzes. 
For SE specific IgA analysis, 96 well plates (Corning Costar Corp., 
Cambridge, MA, USA) were coated with 100 microliters (ml) of SE whole cell 
antigen (10 mg/ml) in carbonate-bicarbonate buffer (pH 9.6) and incubated 
overnight at 4 ℃ and washed four times with Tris Buffered Saline with Tween 
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20 (TBST, pH 8) in a plate washer (Immunowash® Bio-Rad, Hercules, Canada).   
Blocking of non-specific binding sites was carried out with 150 ml of 1% BSA in 
TBS (pH 8) for one hour and washed four times. One hundred microliters of test 
samples: bile (1:100) and cecal contents (1:100) diluted in sample diluent (TBS 
+ 1% BSA) was incubated into the designated wells for 1 hour, followed by four 
washes of TBST. The plates were incubated for one hour using with 100 ml of 
Rabbit Antichicken IgA conjugated Horseradish Persoxidase (Bethyl 
Laboratories, Inc., Montgomery, TX, USA) diluted 60,000 times. Plates were 
subsequently washed 6 times with TBST.  All incubations were carried out at 
37℃ with shaking.  For color development, 50 ml of 3, 3’, 5, 5’ Tetramethyl 
benzidine (TMB) Liquid Substrate System (Sigma-Aldrich, St. Louis, MO,USA) 
was incubated for 1 hour and the enzymatic reaction was stopped using 50 ml 
of 0.5 M H2S04.    Plates were read in an ELISA reader (Bio-Rad®) with an 
absorbance set to 450 nm.  All samples were tested in triplicates and the SE 
specific antibodies were arbitrarily expressed as the average absorbance of the 
three replicates. 
 
Histopathology  
At 23 days p.i., sections of the liver, spleen, bursa of Fabricius, cecal 
tonsils and ceca (cross-section) were fixed in 10% buffered formalin for 24 hours, 
sectioned at 4 mm thickness, and embedded in paraffin.  Slides were stained 
using routine Hematoxylin and Eosin (H & E) stain and Giemsa stain and then 
examined under light microscope [Nikon® Digital Camera DXM 1200F 
microscope (Melville, New York) equipped with Nikon Eclipse® E8000 Camera].  
A scoring system for the cecal tonsils was applied.  The quantification of 
intraepithelial lymphocytes was based on the protocol described by Sheela et al., 
(2003).  Typical enteric Salmonella paratyphoid lesions were evaluated and 
were judged on the basis of inflammation, hyperplasia of mucous gland cells, 
intraepithelial mononuclear cells in the intestinal villi flanking the cecal tonsils, 
and population of lamina proprial cells (Gast, 2003).  The presence of 
granuloma was also recorded (Desmidt et al., 1998a).  In each of the three to 
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five birds necropsied, five different intestinal villi flanking the cecal tonsils 
were selected at random and the following parameters were evaluated: a) 
Inflammation: (3)-severe, multifocal coalescing areas of hemorrhages and 
edema, (2)-moderate, focal to multifocal areas of hemorrhages and edema, 
(1)-mild, focal areas of hemorrhages and edema. b) Mucous gland cells: 
(3)-severe, generalized hyperplasia and hypertrophy of mucous gland cells, 
(2)-moderate, focal to multifocal areas with hyperplastic and hypertrophied 
mucous gland cells, mostly confined in hemorrhagic and edematous areas, 
(1)-mild, focal areas of hyperplastic and hypertrophic mucous gland. c) 
Intraepithelial mononuclear cells: counted from 5 different microscopic fields at 
40x magnification:  (3)-Increased, presence of 35 to 50 cells per microcopic field, 
(2)-Moderate, presence of 20 to 34 cells per microscopic field, (1) Mild, presence 
of less than 20 cells per microscopic field. d) Lamina proprial cell population:  
(3)-increased, lamina propria was densely infiltrated with mononuclear cells 
consisting of mature lymphocytes, plasma cells, and macrophages (2)-moderate, 
lamina propria was moderately infiltrated with mononuclear cells (1)-mild, 
lamina propria was mildly infiltrated with mononuclear cells. The slides 
stained with H & E were used in the evaluation of parameters a, b, and d. 
Giemsa stained slides were used in the enumeration of intraepithelial 
mononuclear cells.  
 
Statistical analyzes 
Statistical differences between treatment groups were determined by one 
way analysis of variance (ANOVA).  The means derived from the 
quantification of bacteria from faecal samples and organs, IgA and IgG 
absorbances were analyzed on each sampling schedule and were further 
separated for significance with an all pairwise multiple comparison applying 
the Tukey- Kramer test (P < 0.05, Graphpad Instat 3®, California, USA).  
Histopatho-  logical scores,where applicable were analyzed using 
Kruskall-Wallis test for non-parametric ANOVA (P < 0.05) using the same 
software.  
１６ 
Results and Discussion 
SE shedding and bacterial count in organs 
The body weights are summarized in Figure 6.  The objective of this trial 
is not to ascertain dietary effects on broiler weight gain but this information 
may provide economic justification of the cost of the additive and baseline 
insights for future studies (i.e. egg layer and broiler breeder performances).  
MAN-fed birds exhibited the heaviest final body weights that averaged to 1746 
grams followed by the control birds with an average weight of 1672 grams. The 
MCM-B1-fed birds exhibited heavier body weight gain at days 21 and 28 yet 
averaged to a final body weight of 1561 grams. The weight gain was influenced 
by age “effect” (p = 0.0001), and not as a result of diet and age interaction (p = 
0.1546), or diet effect (p = 0.1329).  This is similar to the observations of 
Juskiewicz et al., (2003), in MOS-fed turkeys, where no significant influence on 
weight gain and growth rate observed during the first four weeks of life.  The 
dose and duration of feeding may also affect the over-all influence of the diet 
(Zdunczyk et al., 2005), as was observed in the weights of MCM-B1-fed birds 
after the end of the two week of feeding but not at end-point. 
The faecal shedding in birds fed MCM-B1 (6.36 log10CFU, P≤0.001) and 
MAN (6.48 log10CFU, P≤0.01) at 24 hours post-infection (p.i.) were slight lower 
compared with the control (8.38 log10CFU) (Figure 7), but thereafter, the MAN- 
and MCM-B1-fed birds exhibited different shedding patterns towards the 
resolution of the infection.  SE shedding peaked at 4 day p.i. then decreased 
gradually in both groups but a marked decrease in shedding observed in birds 
fed MCM-B1 as early as 7 days p.i. ( 2.25 log10CFU, P < 0.001), and thereafter 
until 19 days p.i. (< 0.10 log10CFU, P < 0.001). In contrast, birds fed MAN 
displayed a more protracted SE shedding, having significantly reduced SE 
levels at 19 days p.i. (3.68 log10CFU, P < 0.05).  
 
１７ 
 
To obtain a more accurate estimate of the intestinal SE, at each necropsy, 
the cecal SE levels were analyzed (Table 4). In MCM-B1-fed birds, the cecal 
contents analyzed at various time points reflected the fecal shedding.  
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Figure 6   Change of average body weight from prevention trial comparing three 
different diets. Vertical bars represent standard error.  n=5.  Diet effect: p 
= 0.1329, age effect:  p = 0.0001, diet and age interaction: p = 0.1546. 
 
Figure 7   Faecal Salmonella Enteritidis counts from prevention trial 
Mean SE log10 CFU/gram ± S.E.M.(n=5). a- significant differences with 
control. b- significant differences with Mannose (MAN) (P < 0.05, Tukey 
Kramer Test, Graphpad Instat 3™) 
 
0
1
2
3
4
5
6
7
8
9
10
1 4 7 10 13 16 19
lo
g
1
0
 C
F
U
/g
ra
m
 
days post-infection 
MAN
MCM-B1
CONTROL
a 
a,b 
a,b 
a,b a,b 
a 
a 
１８ 
Interestingly, at 14 days p.i., the cecal levels were slightly higher than the 
faecal shedding at 13 days p.i. (4.77 log10 CFU).  By 23 days p.i., the CFU level 
in the ceca was below the detection limit in all birds necropsied (< 0.10 
log10CFU, P≤0.001) and reflected the levels of SE in the faeces (<       
0.10 log10CFU).  MAN-fed birds on the other hand, have ower mean SE cecal 
carriage at day 23 (2.89 log10CFU) compared with the control (6.34 log10CFU), 
but these levels were not statistically significant. The SE levels in the liver was 
reduced in birds fed MAN (P < 0.05) and MCM-B1 (P < 0.05) starting at 7 days 
p.i. and thereafter, with mean SE not exceeding 2.5 log10CFU compared with 
the control (ranged from 4.89 to 6.71 log10CFU) (Table 4). 
 
Table 4  The effect of dietary MCM-B1 or MAN provided for two weeks after hatching on the numbers of 
Salmonella Enteritidis in the liver and cecal contents of broilers infected at 15d of age1. 
                                                                                     
Days post-infection 
                                                                                     
1    7  14           23 
                                                                                              
Liver 
MAN   4.19 ± 0.43 (5/5)a       < 0.1  (0/5)a     1.15 ± 0.66(2/5)a  2.46 ± 0.05(5/5)a 
MCM-B1   5.61 ± 0.38 (3/5)    1.64 ± 0.71 (2/5)a     1.61 ± 0.48 (2/5)a  1.76 ± 0.54 (5/5)a 
 CONT.     5.52 ± 0.17 (3/5)    4.89 ± 0.29 (5/5)     5.90 ± 0.21 (5/5)     6.71 ± 0.51 (5/5) 
 
Cecal contents 
 MAN   5.78 ± 0.22 (5/5)    7.09 ± 0.82 (5/5)     3.73 ± 1.21 (2/5)     2.89 ± 1.10 (2/5) 
 MCM-B1   7.74 ± 0.23 (5/5)    5.39 ± 0.71 (5/5)     4.77 ± 0.55 (5/5)       < 0.1   (0/5)a 
 CONT.   7.50 ± 0.47 (5/5)    5.85 ± 0.75 (5/5)     4.99 ± 0.69 (3/5)     6.34 ± 1.98 (3/5) 
                                                                                                
1Chicks were inoculated with 2×107 cfu with Salmonella enteritidis at 15d of age. 
Mean SE log10 CFU/gram ± standard error of the mean (S.E.M.), (n=5). 
asignificant differences with control.  (P < 0.05, Tukey Kramer Test, Graphpad Instat 3™). 
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The protracted nature of SE clearance in the ceca of MAN fed birds was 
similar to the findings of Fernandez et al (2002) in birds MOS, where 
significant reduction in SE cecal carriage was observed in the later stages of 
infection.  The colonization of SE in the liver was reduced in MAN- and 
MCM-B1-fed birds indicating a restrained systemic dissemination of the  
organism. The spleen results were eliminated from the table as positive spleens 
were detected occasionally in all experimental groups. The exact influence of 
MAN and the mannose-oligosaccharides in the systemic colonization of 
pathogens is yet to be ascertained. Newman (1994) proposed that mannose 
stimulates the secretion of mannose-binding proteins.  Mannose-binding 
protein secretion can bind to bacteria resulting to the trigger of the complement 
cascade pathway of the bird immune system.   
In various investigations of the effects of oligosaccharide feeding on the 
immune system, IgA production was extensively explored as IgA is an 
important component of mucosal defense against enteric pathogens and 
maintenance of the integrity of the mucosal biofilm (Bollinger et al., 2003).  In 
turkeys fed mannan- oligosaccharides, bile IgA levels were increased (Savage et 
al., 1996), while in mice models, derivatives of mannan-oligosaccharides such 
as glucomannan (Kudoh et al., 1999), and water soluble konjak mannan (Lim et 
al., 1997) have been reported to modulate IgA production.  However, 
information has been lacking regarding carbohydrate feeding and the 
production of pathogen specific IgA response and if the same 
immunomodulatory effects are achieved in the presence of an enteric infection.  
IgA is required to abate infection by interacting with pathogens in the lumen 
allowing their exclusion from the gut and prevention of further colonization 
(Brandtzaeg et al., 1987).  SE-specific IgA, in particular has been 
demonstrated to block the penetration of SE in intestinal cells in vitro 
(Sugita-Konishi et al., 2000).  In this present study, simultaneous detection of 
cecal and bile IgA antibodies were applied at various time points to characterize 
the dynamics of SE-specific IgA production in response to SE infection.  The 
cecal IgA levels in MAN, MCM-B1, and control groups peaked at 14 dpi. (Figure 
２０ 
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8a).  A waning IgA levels in the cecal contents were detected in the control 
birds but the IgA levels persisted until 23 days p.i. in birds fed MAN and 
MCM-B1.  In the bile (Figure 8b), an increasing trend of SE IgA levels were 
detected and peaked at 23 days in MAN- and MCM-B1-fed birds.  In contrast, 
a transitory increase (day 7) in bile IgA were detected in the control birds with 
levels tapering off at 14 and 23 days p.i.  The high and persistent SE IgA 
response of MCM-B1- and MAN-fed birds paralleled the decline in SE shedding 
and cecal carriage at the later stages of infection indicating an influence of the 
diet on IgA production and SE clearance.  Other aspects of mucosal immunity 
associated with oligosaccharide feeding have been extensively reviewed (Gibson 
et al. 2005;  Kleessen & Blaunt 2005;  Schley & Field 2002;  Watzl et al. 
2005) and different immunomodulatory mechanisms have been hypothesized 
including: 1) selective increase/decrease in specific bacteria which modulate 
cytokine and antibody production; 2) increased in intestinal SCFA production to 
G-coupled protein receptors on leukocytes, and; 3) interaction with 
carbohydrate lectins.  However at this point, the exact immunological 
mechanisms underlying the production of IgA in oligosaccharide-fed animals 
are not well defined.  
 
 
     
 
 
 
 
Figure 8   Specific IgA levels in cecal and bile contents. Mean absorbance of cecal IgA (a), 
and bile IgA (b). Vertical bars represent standard error of the mean (n=5).  
a – significant difference with the control (P < 0.05, Graphpad Instat 3™). 
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Histological scores  
Information on the histological changes associated with the feeding of 
MAN/MCM-B1 in the face of an infection has been lacking.  It is worthwhile to 
mention here that MAN/MCM-B1 and SE are both recognized by the mucosal 
immune cells as foreign (Iqbal et al., 2005) and at this stage of infection, the 
effects of either MAN/MCM-B1 or SE can not be delineated.  However, the 
purpose of the histological evaluation was to compare the effects of the diet on 
mucosal damage and repair, inflammation, and activity of the gut associated 
lymphoid tissue (GALT) towards the resolution of SE infection.  This data 
provides insights and possible correlation to the bacterial isolations and 
serological analyzes.  The histological scores are summarized in Table 5.   
 
Table 5  Histopathological examination at 23 days p.i. from prevention trial. 
                                                                                                         
                           MCM-B1     MAN       CONTROL 
                                                                                                                                                                                                               
Parameters  
Inflammation            Mild (0.00)*          Mild (0.33)*    Moderate (2.66) 
Mucous gland cell hyperplasia     Mild (1.00)*  Mild (1.00)*    Moderate(2.00) 
Intraepithelial mononuclear cells  Increased (2.00)*  Moderate (2.00)*     Mild (1.00) 
  
Lamina proprial cell population  Increased (2.66)*  Moderate (2.00)    Moderate(1.66) 
Other lesions: 
Necrosis of villous tips   Mild   Mild     Mild to moderate 
Granuloma (cecal tonsils)  None   Yes     Yes  
                                                                                                                                                                                                               
Values in parentheses indicate average histopathological scores.  * significant difference with the control (P  
< 0.01, Kruskall Wallis for non-parametric analysis, Graphpad Instat®).  
 
A lower inflammation score characterized by a mild focal hemorrhage and 
edema and mild mucous gland cell hyperplasia were observed in birds fed 
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MCM-B1 and MAN indicating a subtle inflammatory change and apparent 
clearance of the offending organism compared with the control where a 
multifocal moderate to severe hemorrhages were observed.  Chronic 
granulomatous lesions in the cecal tonsils was found in f the control and MAN 
fed birds, a common finding in SE phage type 4 infection in birds (Desmidt et 
al., 1998a) indicating a persistent infection and uncontrolled colonization 
(Figure 9).  A significantly increased number of intraepithelial mononuclear 
cells (mature lymphocytes and macrophages) were observed in the lining 
epithelium of birds fed MCM-B1 and accompanied by an increased number of 
lamina proprial (lp) cells.  The MAN-fed birds exhibited a moderate increase 
in intraepithelial mononuclear cell population but insignificant population of lp 
cells (Table 5).  This moderate to increased population of lp cells in MCM-B1 
and MAN-fed birds confirmed the IgA levels detected by ELISA. The 
histological changes exhibited by birds fed MCM-B1 demonstrated increase 
mucosal protection to SE, exhibited by the presence of mild focal hemorrhages 
(Figure 10a).  Moderate to severe multifocal hemorrhages with early 
formation of granulomas were observed in birds fed MAN and regular diet 
(Figure 10 b,c).   Improved cell mediated immune responses (i.e. presence of 
mature lymphocytes) may explain the clinical recovery to SE (cecal carriage 
and fecal SE).  Robust lymphoid response in the gut mucosa exhibited by 
turkeys fed dietary MOS (Sims et al., 2004), and mice models fed various types 
of non-digestible oligosaccharides (Hosono et al., 2003; Lim et al., 1997), but the 
exact changes occurring in the event of an infection in most dietary 
interventions has not been described elsewhere limiting the interpretation of 
the histological changes.   
In conclusion, this chapter indicates that feeding MCM-B1 during the 
first two weeks of growing reduces the susceptibility of birds to SE by 
influencing antibody responses, and integrity of the gut mucosa.  When 
MCM-B1 is fed in the face of an infection, 2 weeks of feeding can significantly 
reduce the cecal carriage and shedding of broiler birds but up to 3 weeks of 
feeding may be necessary for MAN to bring the SE to a significantly low level.  
２３ 
MCM including MNB is therefore safe, practical, and economical alternative to 
antimicrobials for the reduction of SE in broilers. 
This is an Author’s Accepted Manuscript of an article published in the 
British Poultry Science ( Effect of dietary MNB in the prevention of Salmonella 
enteritidis infection in broilers), published online , at 19 June 2007, available 
online at http://www.tandfonline.com/ doi/full/10.1080/00071660701 370442, 
and the copyright of the paper of British Poultry Science Limited. 
２４ 
Figure 9   Chronic granulomatous inflammation in the cecal tonsils (black arrows).   
Control bird (a), MAN-fed bird (b), MCM-B1-fed bird (c). The scale bar is 100 μm. 
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Figure 10   Histopathological examination at 23 days p.i. of cecal tonsils.  
Villi flanking the cecal tonsils of birds fed MCM-B1 (a), MAN (b), and control (c).   
Black arrows indicate hemorrhagic lesions, White arrows in (c) indicates early 
granulomas. The scale bar is 100 μm. 
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Chapter Ⅲ 
Analysis of gut immune-modulating activity of β1,4 mannobiose (MNB) using 
microarray and real-time RT-PCR 
 
Introduction 
Normal functioning of the immune system is crucial to overall health, and 
diet is one of the major exogenous factor modulating individual 
immunocompetence. Enteric diseases are an important concern to the poultry 
industry because of lost productivity, increased mortality, and the associated 
contamination of poultry products for human consumption. With increasing 
concerns about antibiotic resistance, the ban on sub-therapeutic antibiotic 
usage in Europe and the potential for a ban in the United States, there is 
increasing interest in finding alternatives to antibiotics for poultry production. 
The gastrointestinal tract is the largest immune system; it contains 80% of all 
antibody-producing cells and produces antibodies more efficiently than any 
other part of body (Helgeland and Brandtzaeg, 1999). The chicken intestine has 
a organized scattered immune cells called gut-associated lymphoid tissues 
(GALT), comprised of Peyer’s patches, (PP),  lamina propria lymphocyte (LP), 
intraepithelial lymphocytes (IEL) and cecal tonsil (CT) (Shira et al., 2005).   
The intestinal microbiota, epithelium, and immune system provide 
resistance to enteric pathogens. Recent data suggest that resistance is not 
solely due to the sum of the components, but that cross-talk between these 
components is also involved in modulating this resistance. Inhibition of 
pathogens by the intestinal microbiota has been called bacterial antagonism, 
bacterial interference, barrier effect, colonization resistance, and competitive 
exclusion (Patterson and Burkholder, 2003). Probiotics and prebiotics are 
components present in foods, or that can be incorporated in to foods, which 
beneficially modulate gut immune responses. Recently, probiotics and 
prebiotics have attracted a great deal of notice for their effects on health 
promotion via changes in human-intestinal microbiota. Prebiotics are expected 
to exert beneficial effects on the prevention of pathogenic bacteria growth, the 
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production of antimicrobial agents, and the stimulation of mucosal barrier 
function in the initial developmental stage and immunomodulating effects in 
the late stage (Novak and Katz, 2006). No information, however, is available on 
how host organisms recognize ingested prebiotics in the process of expressing 
the immunomodulating effects and subsequent events. 
The dominant prebiotics are fructo-oligosaccharide products (FOS, 
oligo-fructose, inulin). However, trans- galacto-oligosaccharides, gluco- 
oligosaccharides, glycol-oligosacchriades, lactulose, lactitol, maltooligo- 
saccharides, xylo-oligosaccharides, stachyose, raffinose, and sucrose thermal 
oligosaccharides have also been investigated (Collins and Gibson, 1999; 
Patterson et al., 1997). Mannan oligosaccharides (MOS) are one of the most 
popular commercially available prebiotics for poultry use (Ferket, 2004). 
Although MOS have been used in the same manner as the prebiotics listed 
above, they do not selectively enrich for beneficial bacterial populations. 
Instead, they are thought to act by binding and removing pathogens from the 
intestinal tract and by stimulation of the intestinal immune system (Spring et 
al., 2000; Shashidhara and Devegowda, 2003).  
We have previously demonstrated that dietary supplementation of MCM 
including the disaccharide MNB could prevent SE infection in broilers, by 
increasing IgA production and improving SE clearance (Agunos et al., 2007). 
However, the mechanism of action of MNB has yet to be elucidated. It is thus 
important to clarify the mechanisms of the immunomodulating effects of MNB 
in the host intestine in order to understand how host intestinal immune 
systems are modulated by food components. DNA microarray technology allows 
the analysis of the expression of many genes simultaneously, in order to further 
examine the effect of MCM including MNB on the intestine, as well as to 
identify potential novel biomarkers associated with its physiological function. 
The objectives of this chapter were to confirm the immunomodulatory 
effects of MCM including MNB in chickens and carry out a comprehensive 
analysis to determine the effects of MNB on gene expression in the intestine 
and mucosal immune system by microarray and quantitative real-time 
２８ 
RT-PCR. 
 
Materials and Methods 
Animals and experimental design 
One-day-old chicks (Ross x Ross) were obtained from a local commercial 
hatchery. Chicks were randomly divided into two groups (n = 12)  and housed 
at the Animal Isolation Unit (University of Guelph, Guelph, Ontario) in raised 
wire cages with free access to feed and water. Foil was placed under the wire 
cages to collect droppings. The starter or grower crumble feeds used in this 
chapter did not contain antibiotics or anticoccidial drugs and were prepared at 
the University of Guelph, Guelph, Ontario. All experiments were approved by 
the University of Guelph Animal Care Committee and carried out in accordance 
with the Canadian Council of Animal Care Guide to the Care and Use of 
Experimental Animals. 
 
Supplementation with MNB 
MNB (MCM-B2) was derived from copra meal by enzymatic digestion, and 
was provided by Fuji Oil, Ltd. (Osaka, Japan). The supplement contained 
67.8% MNB (w/w), with the remainder composed of mannose (8.9%), arabinose 
(0.4%), galactose (2.6%), glucose (5%), fructose (2.3%), sucrose (0.2%), protein 
(9.7%) and ash (3.1%) (Data provided from Fuji R&D). MCM-B2 was 
administered three times per week via oral gavage for four weeks, at the 
following doses: 3, 8, 15, and 18 mg/chick during weeks 1, 2, 3, and 4, 
respectively. MCM-B2 dose was based on previously reported supplementation 
of chicks with 0.1% MCM-B1 in feed (Agunos et al., 2007). Negative control 
animals received the same volume of vehicle (sterile water) by oral gavage. 
 
Body weight and histopathology 
Body weights were recorded weekly. On day 14 and 28, half of the animals 
in each group were humanely euthanized, and weights of spleen and bursa of 
Fabricius were recorded. Results were expressed as the percent organ weight 
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relative to body weight for each animal. Samples of ileum, jejunum, cecum, 
spleen, thymus and bursa of Fabricius were fixed in 10% formalin followed by 
staining with hematoxylin and eosin (H&E).  
 
Collection and processing of fecal samples  
Fecal samples were taken weekly from each group by collecting droppings 
from five random locations beneath each cage, and were stored at -80°C until 
analysis. Samples were weighed, diluted 1:3 with PBS and mixed thoroughly. 
Clarified supernatant was obtained by centrifuging at 4000 rpm for 20 min at 
4°C, and was stored at -80°C until IgA concentrations were measured (Tress et 
al., 2006).  
 
IgA enzyme-linked immunosorbent assay  
Fecal total IgA quantification was carried out using a Chicken IgA ELISA 
Quantitation Set according to the manufacturer’s instructions (Bethyl 
Laboratories, Inc., Montgomery, TX). Briefly, 96-well plates (Corning Inc., 
Corning, NY) were coated with 100 μL of anti-chicken IgA capture antibody, 
diluted 1:100 in 0.05 M sodium carbonate buffer, pH 9.6, and incubated for 1 hr 
at 37°C. Plates were then washed with TBS containing 0.05% Tween-20 (TBST) 
and blocked for 30 min with TBS containing 1% (w/v) BSA (Thermo Fisher 
Scientific, Inc., Waltham, MA). IgA standards and samples were diluted in 
TBST containing 1% (w/v) BSA, and 100 μL/well was added to the plates and 
incubated for 1 hr at 37°C. Plates were washed and then incubated for 1 hr at 
37°C with HRP-conjugated chicken IgA detection antibody, diluted 1:50000 in 
PBST containing BSA. Detection was carried out using 3, 3’, 5, 5’- 
tetramethylbenzidine (TMB) (Sigma-Aldrich, St. Louis, MO). The reaction was 
stopped with 2 M sulfuric acid (Thermo Fisher Scientific) and absorbances read 
at 450 nm. 
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Microarray and RT-PCR analysis 
On day 28 birds were euthanized and the ileum was removed and stored 
in RNAlater® (Applied Biosystems, Austin, TX) at -20°C until use. Total RNA 
was isolated from ileum samples using QIAGEN RNeasy Mini Kit according to 
the manufacturer’s instructions (Qiagen Inc., Mississauga, Ontario). RNA 
quality was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies 
Inc., Palo Alto, CA) and the RNA 6000 Nano kit (Caliper Life Sciences, 
Mountain View, CA). 
For microarray analysis, all GeneChips were processed at the London 
Regional Genomics Centre (Robarts Research Institute, London, Ontario, 
Canada; http://www.lrgc.ca). Biotinylated complimentary RNA (cRNA) was 
prepared from 1.0 μg of total RNA using the MessageAmp II-Biotin Enhanced 
Single Round aRNA Amplification kit (Applied Biosystems, Austin, TX). Ten μg 
of labeled cRNA was hybridized to the GeneChip® Chicken Genome Array 
(Affymetrix, Santa Clara, CA) for 16 hours at 45°C as described in the 
Affymetrix Technical Analysis Manual. GeneChips were stained with 
Streptavidin-Phycoerythrin, followed by an antibody solution and a second 
Streptavidin-Phycoerythrin solution, with all liquid handling performed by a 
GeneChip Fluidics Station 450, and were scanned with the Affymetrix 
GeneChip Scanner 3000 (Affymetrix). Probe signal intensities were generated 
using GCOS1.3 (Affymetrix) using default values for the Statistical Expression 
algorithm parameters and a Target Signal of 150 for all probe sets and a 
Normalization Value of 1. Gene level data was generated using the RMA 
preprocessor in GeneSpring GX 7.3.1 (Agilent Technologies Inc.).  Data were 
then transformed (measurements less than 0.01 set to 0.01) and normalized per 
chip to the 50th percentile, and per gene to control samples.  Fold change and 
t-tests were then run using GeneSpring GX. 
First-strand cDNA synthesis was carried out using the iScript™ cDNA 
Synthesis Kit (Bio-Rad Laboratories, Inc.) according to the manufacturer’s 
instructions. Real-time PCR was carried out using iQ™ SYBR Green Supermix 
(Bio-Rad Laboratories, Inc.) on a MyiQ™ Single Color Real-Time PCR Detection 
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System (Bio-Rad Laboratories, Inc.) using the following conditions: 
denaturation 15 s at 95°C, annealing 15 s at 56 °C, and extension 30 s at 72 °C. 
Primers for chicken GAPDH, interferon regulatory factor (IRF)-1, IRF-7, major 
histocompatibility complex (MHC) beta 1 doman (BLB-1), MHC class I 
glycoprotein (BF-2), tumor necrosis factor (TNF) (ligand) superfamily member 
15 (TNFSF15), and Toll like receptor (TLR) 3 (Table 6) were designed using 
Primer3 v.0.4.0 (Rozen and Skaletsky, 2000) and synthesized by the University 
of Guelph Laboratory Services Molecular 
 
 Table 6  Chicken primers used for real-time RT-PCR. 
 
Biology Section (Guelph, ON). Results are expressed as relative mRNA levels 
compared to GAPDH. 
 
Statistical analysis  
Statistical analyzes to compare MCM-B2-treated and control groups were 
carried out using Student’s t test. Statistical significance was determined using 
the GraphPad Prism statistical software (San Diego, CA, USA). A P-value of less 
than 0.05 was defined as significant. 
 
Gene 
 
Forward primer (5’-3’) 
 
Reverse primer (5’-3’) 
Product 
(bp) 
Accession 
number 
GAPDH CAA CAT CAA ATG GGC AGA TG AGC TGA GGG AGC TGA GAT GA 130 NM_204305 
IRF-1 GGA GGA GTC AGC AGA ACG AC CGC AGG ACG AGA GGT CTA AG 131 NM_205415   
IRF-7 TCA GGG TGT TTT GCA CAG AG ACC AGC TTC ACC AGG ATG AG 142 NM_205372 
BLB-1 ATG CAG TGG ATA CGT TCT GC GGT AGA AGC CCG TCA CGT AG 153 NM_001044694 
BF-2 ATC GTG GTT GGT GTT GGA TT GTG TGG ACT GTT GGC TCC TT 168 NM_001031338 
TNFSF15 AAG CCA AGA GCA CAC CTG AC CAG GTA TCA CCA GTG CGT TG 148 NM_001024578 
TLR3 GAT CCA TGG TGC AGG AAG TT GCA CAG GGG GCA CTT TAC TA 250 NM_001011691 
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Results 
Body weights were recorded weekly, and are summarized in Figure 11. No 
significant difference was observed between the weight gain in chicks fed the 
control diet and those supplemented with 0.1% MCM-B2 over 4 weeks. 
Likewise, no significant difference was observed in the relative organ weights 
of spleen (Figure 12A) and bursa of Fabricius (Figure 12B) between the two 
groups on day 14 or day 28. No significant histopathological changes were 
observed in any of the tissues examined (ileum, jejunum, caecum, spleen and 
bursa of Fabricius) from either control or MNB-treated animals (data not 
shown). 
Fecal samples were collected weekly, and the concentrations of fecal total 
IgA levels were measured by ELISA (Figure 13). While total IgA levels 
continued to increase throughout the duration of the trial in both groups, 
MNB-supplemented animals showed higher (P < 0.05) concentrations of fecal 
IgA at all time points when compared to animals fed the control diet, further 
supporting the immunomodulatory role of MNB.    
Analysis of microarray data revealed that the ileum expression of 171 of 
the 38,535 genes studied was significantly influenced by the administration of 
MNB for four weeks. Affected genes were investigated for their involvement in 
biological functions and classified based on known biological functions 
according to Gene Ontology (Table 7). Up- and down-regulated genes are 
summarized in Tables 8 and 9. The identified up- or down-regulated genes were 
found to be related to a number of different cellular functions (Table 8). Among 
the genes that were significantly up-regulated by MCM-B2 administration, 30 
were directly related to immune response and host defense, including MHC 
class I and II, TNFSF15, interferon (IFN) and IFN regulatory factors (IRF-1, 
IRF-7, IFIT5 and IFITM1), as well as genes involved in pathogen recognition 
(TLR3) and innate immunity and host defense (lysozyme and Mx protein). 
However, several genes classified as participating in other cellular functions, 
such as signal transduction and physiological processes and cellular 
metabolism, are also indirectly related to immune responses and were found to 
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be up-regulated by MCM-B2. These genes included cysteine-rich angiogenic 
inducer 61 (CYR61), signal transducer and activator of transcription 1 (STAT1), 
complement component 1, radical S-adenosyl methionine domain containing 2 
(RSAD2), and CD69. As a result, the number of up-regulated genes directly or 
indirectly related to immune responses was 37 out of 171, or 22% of 
significantly influenced genes. 
In order to validate the microarray data, real-time quantitative RT-PCR 
was carried out on six genes selected as candidate biomarkers of MNB activity. 
BLB-1 BF-2, IRF-1, IRF-7, TNFSF15 and TLR3 were all up-regulated (P < 0.05) 
(Figure 14) in the ileum of MCM-B2-treated birds, consistent with the 
microarray data. Their up-regulation observed here, as well as the importance 
of the genes in host defense and immune responses would suggest that these 
genes may serve as markers of the physiological and immunomodulating 
activities of MNB. 
 
Discussion 
Mannose-containing oligosaccharides are one of the most common 
commercially available prebiotics for poultry use, however, little is known 
about their effect on the intestinal immune system. We previously observed 
that chickens fed MCM including MNB had increased IgA production and 
improved S. enteritidis clearance (Agunos et al., 2007), suggesting that it may 
act as an immunomodulatory agent to enhance innate and adaptive immune 
responses. In the present study, we evaluated the effect of the administration of 
MCM including MNB alone, without bacterial challenge, in order to elucidate 
the role of MNB on the intestinal immune system, and carry out a 
comprehensive evaluation of the effect of MNB on gene expression in the 
intestine by microarray analysis. 
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Table 7 Function-based classifications of genes for which expression in ileum were 
significantly influenced by administration of MCM-B2 for 28 days. 
 
 Number of genesa 
Function up-regulated down-regulated 
Immune response 30 0 
Physiological processes and metabolism 16 25 
Signal transduction 6 1 
Protein complex and signal translation 3 0 
Catalytic activity 7 14 
Nucleotide binding 16 4 
Others 24 21 
Unknown 2 2 
   
Total 104 67 
a Number of genes significantly influenced by MCM-B2 administration (P < 0.05) 
 
Figure 11 Change in mean body weights of chicks fed control diet (open bars) or 
supplemented with MCM-B2 (shaded bars) for 28 days. Bars represent means ± 
SEM of n = 12 (days 1, 7 and 14) or n = 6 (days 21 and 28) animals. 
 
No significant changes were observed in body or organ weight between 
３５ 
MCM-B2-treated and untreated birds. This is consistent with reports by 
Agunos et al. (2007) and Juskiewicz et al. (2003), in which supplementation 
with mannose-containing oligosaccharides had no noticeable effect on weight 
gain.  
Secretory IgA plays an important role in protecting against infection in 
the intestinal immune system, and its secretion was previously shown to be 
increased by dietary MNB in chickens infected with SE (Agunos et al., 2007). 
Here we found that administration of MNB induced a similar increase in fecal 
IgA levels. This is in line with previous reports of increased IgA production in 
mice fed dietary FOS (Hosono et al., 2003; Nakamura et al., 2004), where it was 
observed that FOS could alter the microbial environment of the gut, and 
up-regulate both mucosal immune responses for protective immunity, but also 
systemic immune responses (Hosono et al., 2003).   
Among the genes that were significantly up-regulated by MNB 
administration, 37 (22% of all affected genes) were directly or indirectly related 
to immune responses. This suggests that one of the major physiological roles of 
MNB administration is immunomodulation in the small intestine.   
Four out of the five represented genes relating to antigen presentation 
(both MHC I and II) and processing were up-regulated. The MHC molecule 
plays an important role in the regulation of the immune response by 
communicating among different cellular components of the immune system 
(Lamont, 1998). Expression of MHC class I antigen on the cell surface requires 
expression of multiple genes and peptide transporters associated with antigen 
processing, including (TAP-1) and TAP-2 (Guo et al., 2002), which was found to 
be up-regulated here by MCM-B2, suggesting MNB may act as an essential 
factor for expression of MHC molecule on cell surfaces. Studies have 
demonstrated an association between the chicken MHC and antibody 
production against variety of antigens (Dunnington et al., 1992; Weigend et al., 
2001) and Zhou and Lamont (2003) reported the genomic region bearing MHC 
class I and II genes had significant effects on antibody response kinetics to 
SRBC and Brucella abortus and antibody levels to SE vaccination.  
３６ 
Of the ten represented genes associated with host defense against 
organisms, MCM-B2 administration up-regulated all ten, including lysozyme, 
an antimicrobial protein important in innate defense which functions to protect 
against microbial attack in the gastrointestinal tract (Ganz, 2004), and 
TNFSF15, which is primarily expressed in spleen, liver, intestinal epithelial 
lymphocytes (IEL), peripheral blood lymphocytes and bursa (Park et al., 2007), 
and is involved in the differentiation, proliferation and apoptosis of immune 
cells (Collette et al., 2003). Like human TNFSF15, it has been reported that 
chicken TNFSF15 also possess cytotoxic activity against tumor cells and it has 
been reported that TNFSF15 transcripts were primarily expressed in CD4+ 
intraepithelial lymphocytes in the duodenum and jejunum following E. maxima 
infection in chickens (Park et al., 2007).  
Interferons (IFN) are important cytokines which regulate antiviral, cell 
growth, immune-modulation and anti-tumor functions, and several IFN-related 
genes were found here to be up-regulated by MCM-B2, including the 
transcription factors IRF-1 and IRF-7. Type I interferons (IFN-α and -β) are 
typically produced upon viral infection and affect the release of 
pro-inflammatory cytokines and nitric oxide by dendritic cells and macrophages 
(Bogdan, 2000). IFN and MHC II also play an important role in the expression 
of secretory IgA in the lamina propria, and increases in both MHC and 
IFN-related genes and IgA production have been observed in mice (Hosono et 
al., 2003; Nakamura et al., 2004; Fukasawa et al., 2007) , and may in part 
explain the concomitant increase in fecal IgA levels and MHC and IFN-related 
gene expression observed in the present study. IRF-1 regulates the expression 
of several genes involved in both innate and acquired immunity. Induced by 
STAT1 (Saha et al., 2009), it also regulates IFN-α/β, IFN-γ, inducible nitric 
oxide synthase (iNOS), MHC class I molecule and beta 2 microglobulin. On the 
other hand, IRF-1 is induced by IFN-α/β, IFN-γ and interleukin (IL)-12 
therefore IRF-1 seems to be positioned at the intersection of different pathways 
leading to a Th1 response and host defense against intracellular 
microorganisms (Miyamoto et al., 1988; Galon et al., 1999). Furthermore, 
３７ 
Fantuzzi et al. (2001) reported that IRF-1 is an important regulator of IL-18 
production and participates in the production of IFN-γ. IRF-7 is the master 
regulator of type-1 IFN-dependent immune responses, and is essential for the 
induction of IFN-α/β genes via the virus-activated MyD88-independent 
pathway and the TLR-activated MyD88-dependent pathway (Honda et al., 
2005). The potent activity of IFN-α/β against viral infections requires the 
expression of IFN-inducible protective genes including 2–5 oligoadenylate 
synthetase (OAS) and MxA protein, both of which were up-regulated by 
MCM-B2, and confer cellular resistance, inhibit viral replication and impede 
viral dissemination, as well as exerting other immunomodulatory effects (Sen 
and Ransohoff, 1993; van den Broek et al., 1995; Hefti et al., 1999) .  
Interestingly, some of the up-regulated genes observed here have also 
been found to be up-regulated in response to infection with Marek’s disease 
virus (MDV) in vitro, including interferon inducible protein, lymphocyte 
antigen 6 complex locus E (LY6E), and macrophage inflammatory protein (MIP) 
(Morgan et al., 2001). Likewise, RSAD2, an IFN-inducible antiviral protein 
(Chin and Cresswell, 2001) was also up-regulated, further supporting the 
potential induction of anti-viral responses by MNB administration.  
 Of these up-regulated genes, 6 were chosen for validation by RT-PCR,as  
possible biomarkers of MNB activity. The up-regulation of BLB-1, BF-2, 
IRF-1, IRF-7, TNFSF15, and TLR3 observed both by microarray and 
RT-PCR, along with the significant up-regulation of a number of genes 
involved in immune response and host-defense would suggest that MCM-B2 
administration may exert a combination effect on the modulation of the 
intestinal immune system. These results are further supported by the 
increased production of IgA observed here, as well as previous observations 
that MCM including MNB could prevent SE infection and improve integrity of 
the gut mucosa in MCM including MNB-fed chickens, indicating that MNB is a 
potent modulator of intestinal immune responses, and further work will be 
required to fully elucidate the mechanism of action of MNB in modulating 
intestinal immune responses. 
３８ 
                                      
  (A)                                  (B) 
Figure 12  Weights of spleen (A) and bursa of Fabricius (B) in chicks fed control diet (open 
bars) or supplemented with MCM-B2 (shaded bars) for 14 or 28 days. Results are 
expressed as percent organ weight relative to body weight of each animal. Bars 
represent means ± SEM of n = 6 animals. 
 
 
 
 
Figure 13  Fecal IgA concentrations from chicks fed control diet or supplemented with 
MCM-B2 for 28 days. Data points represent means ± SEM of n = 12 (days 7 and 
14) or n = 6 (days 21 and 28) animals. *, P < 0.05. 
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 Table 8  Genes significantly up-regulated by MNB administration. 
Functional Grouping Affymetrix ID Gene Description 
Fold 
change 
Immune function    
  Antigen presentation and    GGA.9239.1.S1_S_AT 
similar to MHC 
rfp-y class i alpha 
chain 
2.66 
  processing GGA.417.1.S1_AT MHC class I glycoprotein (BF-2)a 1.83 
 GGA.5137.1.S1_X_AT MHC class II antigen b-l beta 3.54 
 GGA.517.1.S1_X_AT MHC class II beta 1 domain (BLB-1) 4.51 
    
 Defense against organisms GGA.131.1.S1_AT 
myxovirus (influenza virus) resistance 1, 
interferon-inducible protein p78 (mouse) (MX1) 
2.99 
 GGA.5153.2.S1_AT MHC class I antigen (YFV) 1.73 
 GGA.418.1.S1_X_AT 
major histocompatibility complex class I glycoprotein 
(BF2) 
1.78 
 GGA.12614.1.S1_AT 
tumor necrosis factor (ligand) superfamily, member 15 
(TNFSF15) 
1.54 
 GGA.11252.1.S1_AT 
similar to Small inducible cytokine A19 precursor 
(CCL19) (Macrophage inflammatory protein 3 beta) 
(MIP-3-beta) (EBI1-ligand chemokine) (ELC) (Beta 
chemokine exodus-3) (CK beta-11) 
1.99 
 GGA.3357.2.S1_A_AT lysozyme G like 2 1.67 
 GGA.536.1.S1_A_AT 2'-5'-oligoadenylate synthetase-like (OASL) 3.19 
 GGA.518.1.S1_X_AT MHC class II antigen B-F minor heavy chain (BLB1) 2.00 
 GGA.9103.1.S1_AT similar to Lysozyme G (1,4-beta-N-acetylmuramidase) 4.96 
 GGAAFFX.25059.1.S1_AT similar to Lysozyme G (1,4-beta-N-acetylmuramidase) 6.31 
    
        Interferon-related GGA.791.1.S1_AT interferon regulatory factor 1 (IRF-1) 1.51 
 GGA.1087.1.S1_AT interferon regulatory factor 7 (IRF-7) 1.53 
 GGA.16457.1.S1_S_AT interferon induced with helicase C domain 1 (IFIH1) 2.16 
 GGAAFFX.21915.1.S1_AT 
similar to interferon-induced protein with 
tetratricopeptide repeats 5 (IFIT-5) 
2.22 
 GGA.8227.1.S1_S_AT 
putative isg12-1 protein/similar to interferon induced 
transmembrane protein 1 (IFITM1) 
2.50 
 GGA.6201.1.S1_AT putative isg12-2 protein/similar to interferon, 2.64 
４０ 
alpha-inducible protein 6 
 GGAAFFX.23449.1.S1_AT interferon induced with helicase C domain 1  
    
      Other immune functions GGA.2865.1.S1_AT transporter associated with antigen processing 2 (TAP2) 1.52 
 GGA.4225.1.S1_AT leukocyte cell-derived chemotaxin 2 (LECT2) 1.54 
 GGAAFFX.8585.3.S1_S_AT toll-like receptor 3 (TLR3) 1.61 
 GGAAFFX.26422.2.S1_AT 
similar to immune associated nucleotide 6; immune 
associated nucleotide 
1.62 
 GGAAFFX.20099.1.S1_AT heat shock protein 25 (HSP25) 1.70 
 GGA.985.1.S1_S_AT heat shock protein 25 1.72 
 GGA.16267.1.S1_S_AT similar to class i alpha chain 1.86 
 GGA.380.1.S1_AT 
IgA h-immunoglobulin alpha heavy chain [chickens, 
mrna, 1866 nt] 
1.96 
 GGA.1171.1.S1_AT lymphocyte antigen 6 complex locus E (LY6E) 3.57 
    
Protein complex and signal  GGAAFFX.9499.1.S1_AT 
general transcription factor IIE, polypeptide 1, alpha 
56kDa (GTF2E1) 
1.56 
transduction GGAAFFX.10104.2.S1_S_AT 
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit 
D2 (ATP6V0D2) 
1.76 
 GGAAFFX.13119.1.S1_S_AT ribosomal protein S14 (RPS14) 1.52 
    
Nucleotide binding GGA.17642.1.S1_AT ring finger protein 213 (RNF213) 1.62 
 GGA.11337.1.S1_AT 
similar to Torsin B precursor (Torsin family 1 member B) 
(FKSG18 protein) 
1.59 
 GGAAFFX.25830.1.S1_AT K(lysine) acetyltransferase 2A (KAT2A) 1.64 
 GGA.13972.1.S1_S_AT lupus brain antigen 1 (LBA1) 1.58 
 GGAAFFX.8378.1.S1_S_AT 
similar to immune associated nucleotide 6; immune 
associated nucleotide 
1.66 
 GGAAFFX.22137.1.S1_AT PX domain containing serine/threonine kinase (PXK) 1.54 
 GGA.4870.3.S1_A_AT actin, alpha, cardiac muscle 1 (ATCTC1) 1.81 
 GGA.9292.1.S1_AT 
eukaryotic translation initiation factor 2-alpha kinase 2 
(EIF2AK2) 
1.55 
 GGA.8244.1.S1_AT 
cytidine monophosphate (UMP-CMP) kinase 2, 
mitochondrial (CMPK2) 
3.29 
 GGAAFFX.22996.1.S1_AT similar to hypothetical protein flj20035 4.08 
 GGA.9486.1.S1_S_AT La ribonucleoprotein domain family, member 5 (LARP5) 1.66 
４１ 
 GGAAFFX.6546.1.S1_AT 
similar to hect domain and RLD 5; cyclin-E binding 
protein 1 
2.75 
 GGAAFFX.11512.1.S1_AT TRAF-type zinc finger domain containing 1 (TRAFD1) 1.51 
 GGAAFFX.23767.1.S1_AT lupus brain antigen 1 (LBA1) 1.99 
 GGAAFFX.6052.1.S1_S_AT hypothetical LOC422427 4.92 
 GGAAFFX.10498.1.S1_AT 
radical S-adenosyl methionine domain containing 2 
(RSAD2) 
5.11 
    
Signal transduction GGA.2200.1.S1_AT cysteine-rich, angiogenic inducer, 61 (CYR61) 1.99 
 GGA.701.1.S1_AT leukocyte ribonuclease A-2 (RSFR) 1.55 
 GGA.729.1.S1_AT mature avidin 2.24 
 GGA.11597.1.S1_S_AT 
signal transducer and activator of transcription 1, 
91kDa (RCJMB04_17i9) 
1.93 
 GGAAFFX.22313.1.S1_S_AT signal transducer and activator of transcription 1 1.88 
 GGA.1182.1.S1_S_AT 
Mov10, Moloney leukemia virus 10, homolog (mouse) 
(RCJMB04_17i9) 
1.64 
    
Physiological processes and  GGAAFFX.9256.1.S1_S_AT complement component 1, s subcomponent (C1S) 1.51 
cellular metabolisim GGAAFFX.7658.1.S1_AT poly (ADP-ribose) polymerase family, member 9 (PARP9) 1.54 
 GGAAFFX.24484.2.S1_S_AT complement component 1, r subcomponent (C1R) 1.73 
 GGAAFFX.20966.1.S1_S_AT 
similar to hect domain and RLD 5; cyclin-E binding 
protein 1 
2.36 
 GGAAFFX.20602.1.S1_AT zinc finger CCCH-type, antiviral 1 (RCJMB04_23i8) 1.58 
 GGA.990.1.S1_AT hypothetical protein LOC770777 3.75 
 GGA.13502.1.S1_AT PHD finger protein 11 (PHF11) 1.67 
 GGAAFFX.6883.4.S1_S_AT hook homolog 1 (Drosophila) (HOOK1) 1.59 
 GGAAFFX.26344.1.S1_AT zinc finger, NFX1-type containing 1 (ZNFX1) 2.12 
 GGA.1111.1.S1_A_AT ubiquitin specific peptidase 18 (USP18) 2.92 
 GGAAFFX.13227.1.S1_S_AT 
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit 
D2 
1.53 
 GGA.11554.1.S1_AT 
asparagine-linked glycosylation 2 homolog (S. cerevisiae, 
alpha-1,3-mannosyltransferase) (ALG2) 
1.68 
 GGA.3236.1.S1_AT PHD finger protein 11 (PHF11) 1.54 
 GGA.10666.1.S1_AT 
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit 
G3 
1.55 
 GGAAFFX.21777.1.S1_S_AT intestinal zipper protein 2.27 
４２ 
 GGAAFFX.6058.1.S1_AT aminoadipate aminotransferase (AADAT) 1.59 
    
Sugar-binding GGA.4900.6.S1_X_AT CD69 molecule /// similar to C-type lectin-like receptor 1.57 
    
Catalytic activity GGA.12925.1.S1_AT 
structural maintenance of chromosomes flexible hinge 
domain containing 1 (SMCHD1) 
1.64 
 GGAAFFX.10187.1.S1_AT dpy-19-like 4 (C. elegans) (DPY19L4) 1.52 
 GGAAFFX.25763.1.S1_AT tripartite motif-containing 25 (TRIM25) 1.63 
 GGA.1746.1.S1_S_AT similar to kinesin, putative 2.58 
 GGA.12561.1.A1_AT dermatan sulfate epimerase (DSE) 2.07 
 GGAAFFX.1838.1.S1_AT motilin (MLN) 1.73 
 GGAAFFX.5967.1.S1_AT sterile alpha motif domain containing 9-like (SAMD9L) 10.02 
    
Others GGA.12409.1.S1_S_AT similar to gag/env fusion protein 2.06 
 GGAAFFX.4249.1.S1_X_AT WAP four-disulfide core domain 2 (WFDC2) 1.93 
 GGA.10351.1.S1_S_AT 
chromosome 19 open reading frame 12 /// similar to 
RIKEN cDNA 1600014C10 
1.90 
 GGA.10903.1.S1_AT finished cdna, clone chest789c2 1.91 
 GGA.11753.1.S1_AT finished cdna, clone chest393a1 2.92 
 GGA.12098.1.S1_A_AT 
hypothetical gene supported by BX933262; BX935476; 
CR406074 
1.59 
 GGA.12360.1.S1_AT transmembrane protein 213 (TMEM213) 1.61 
 GGA.13146.1.S1_AT epithelial stromal interaction 1 (breast) (EPSTI1) 2.17 
 GGA.13280.1.S1_AT hypothetical protein LOC768499 1.50 
 GGA.14299.1.S1_AT finished cdna, clone chest149k6 4.44 
 GGA.1442.1.S1_AT transcribed locus 1.73 
 GGA.15728.1.S1_AT RCSD domain containing 1 1.66 
 GGA.16084.1.S1_AT similar to promyelocytic leukemia protein 1.63 
 GGA.16635.1.S1_AT sperm associated antigen 4 (SPAG4) 1.88 
 GGA.16860.1.S1_AT hypothetical gene supported by CR391572 1.57 
 GGA.3263.1.S1_AT hypothetical gene supported by cr391572 3.26 
 GGA.4590.1.S2_AT finished cdna, clone chest75j21 1.65 
 GGA.4832.1.S1_AT hypothetical protein LOC770612 1.82 
 GGA.6433.1.S1_AT claudin 2 (CLDN2) 1.60 
 GGA.6770.2.S1_A_AT loc419325 1.53 
 GGA.9930.1.S1_AT finished cdna, clone chest927g24 2.27 
４３ 
 GGAAFFX.10735.1.S1_AT 
MIT, microtubule interacting and transport, domain 
containing 1 (MITD1) 
1.56 
 GGAAFFX.20778.1.S1_AT coiled-coil domain containing 107 (CCDC107) 1.91 
 GGAAFFX.21332.1.S1_S_AT similar to hypothetical protein flj20035 6.59 
    
Unknown AY013303.CDS3.S1_S_AT loc417860 2.96 
 GGA.14508.1.S1_AT 
DnaJ (Hsp40) homolog, subfamily B, member 5 
(DNAJB5) 
1.58 
a Bold text indicates genes chosen for further analysis by real-time RT-PCR 
 
 
Table 9     Genes significantly down-regulated by MNB administration. 
Functional Grouping Affymetrix ID Gene Description 
Fold 
change 
Physiological processes and GGAAFFX.22947.1.S1_S_AT sucrase-isomaltase (alpha-glucosidase) (SI) -2.15 
cellular metabolisim GGA.4248.1.S1_AT lipoprotein lipase (LPL) -1.63 
 GGA.8817.1.S1_S_AT farnesyl-diphosphate farnesyltransferase 1 (FDFT1) -1.64 
 GGAAFFX.26670.1.S1_AT 
solute carrier family 5 (sodium/glucose cotransporter) 
(SLC5A11) 
-1.50 
 GGA.10771.1.S1_S_AT membrane metallo-endopeptidase (MME) -1.89 
 GGA.4447.1.S1_AT phosphoenolpyruvate carboxykinase 1 (soluble) (PCK1) -1.64 
 GGA.11459.1.S1_AT hexokinase domain containing 1 (HKDC1) -1.52 
 GGAAFFX.711.1.A1_AT 
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 
(ST3GAL4) 
-1.63 
 GGA.8851.1.S1_A_AT isopentenyl-diphosphate delta isomerase 1 (IDI1) -1.60 
 GGAAFFX.8317.3.S1_AT 
dopa decarboxylase (aromatic L-amino acid decarboxylase) 
(DDC) 
-1.54 
 GGAAFFX.23557.10.S1_S_AT 
solute carrier family 4, sodium bicarbonate cotransporter, 
member 7 (SLC4A7) 
-1.79 
 GGAAFFX.3997.1.S1_S_AT 
ADP-ribosyltransferase 1 /// GPI-anchored 
ADP-ribosyltransferase (ART1 /// ART7B) 
-1.64 
 GGAAFFX.10596.2.S1_S_AT BMX non-receptor tyrosine kinase (BMX) -1.88 
 GGAAFFX.11774.1.S1_AT serine/threonine kinase 38 like (STK38L) -1.64 
 GGAAFFX.8887.1.S1_S_AT vanin 1 /// vanin 1 (RCJMB04_35g11 /// VNN1) -1.76 
 GGA.2896.1.S1_AT carbonyl reductase 1 (CBR1) -1.58 
４４ 
 GGAAFFX.7796.1.S1_AT 
solute carrier family 39 (zinc transporter), member 8 
(SLC39A8) 
-1.50 
 GGAAFFX.20374.1.S1_AT succinate-CoA ligase, GDP-forming, beta subunit (SUCLG2) -4.33 
 GGA.4990.1.S1_AT collagen, type IX, alpha 1 (COL9A1) -1.62 
 GGAAFFX.25502.1.S1_S_AT 
solute carrier family 2 (facilitated glucose/fructose 
transporter), member 5 (SLC2A5) 
-1.65 
 GGAAFFX.7519.2.S1_S_AT 
solute carrier family 6 (proline IMINO transporter), member 
20 (SLC6A20) 
-4.37 
 GGAAFFX.6121.1.S1_S_AT asparagine synthetase (ASNS) -1.54 
 GGAAFFX.24270.1.S1_AT dermatan sulfate epimerase-like (DSEL) -1.50 
 GGAAFFX.25206.4.S1_S_AT 
folate hydrolase (prostate-specific membrane antigen) 1 
(FOLH1) 
-2.03 
 GGAAFFX.9792.1.S1_AT similar to methionine adenosyltransferase ii, alpha -1.52 
    
Signal transduction GGA.13328.1.S1_AT 
similar to nuclear hormone receptor nor-1 (neuron-derived 
orphan receptor 1) (mitogen induced nuclear orphan 
receptor) 
-1.99 
 
    
Nucleotide binding GGA.5413.1.S1_AT 
DNAJ (Hsp40) homolog, subfamily C, member 15 
(DNAJC15) 
-1.51 
 GGA.6183.1.S1_AT regenerating islet-derived family, member 4 (REG4) -1.63 
 GGA.4939.1.S1_S_AT fatty acid binding protein 4, adipocyte (FABP4) -4.46 
 GGA.10658.1.S1_AT similar to kiaa2019 protein -1.53 
    
Catalytic activity GGA.9991.1.S1_AT sorbitol dehydrogenase (SORD) -1.52 
 GGA.1388.1.S1_S_AT 
alcohol dehydrogenase 1B (class I), beta polypeptide 
(ADH1B) 
-2.04 
 GGAAFFX.5988.1.S1_S_AT sucrase-isomaltase (alpha-glucosidase) (SI) -1.65 
 GGAAFFX.4985.1.S1_AT similar to apical early endosomal glycoprotein precursor -1.79 
 GGA.8880.2.S1_S_AT membrane metallo-endopeptidase (MME) -1.68 
 GGAAFFX.24663.2.S1_S_AT 
similar to huntingtin-interacting protein-1 protein 
interactor; vestrogen-related receptor beta like 1 
-1.51 
 GGA.14230.1.S1_AT dermatan sulfate epimerase-like (DSEL) -1.60 
 GGA.14579.1.S1_AT cubilin (intrinsic factor-cobalamin receptor) (CUBN) -1.66 
 GGA.11227.1.S1_AT bone marrow stromal cell antigen 1 (BST1) -1.55 
 GGA.19409.1.S1_AT collagen, type IV, alpha 2 (COL4A2) -1.50 
４５ 
 GGAAFFX.8477.1.S1_AT 
solute carrier family 5 (sodium/glucose cotransporter), 
member 12 (SLC5A12) 
-2.62 
 GGA.4115.1.S1_AT 
alcohol dehydrogenase 1B (class I), beta polypeptide /// 
alcohol dehydrogenase 1C (class I), gamma polypeptide 
(ADH1B /// ADH1C) 
-1.63 
 GGAAFFX.23840.1.S1_S_AT 
alcohol dehydrogenase 1C (class I), gamma polypeptide 
(ADH1C) 
-1.50 
 GGA.3415.1.S1_AT similar to alcohol dehydrogenase adh-f -1.81 
    
Others GGA.4195.1.A1_AT Similar to BWK-1 -2.22 
 GGA.6324.1.S1_AT retinol binding protein 2, cellular (RBP2) -2.61 
 GGA.9386.1.S1_AT retinol binding protein 7, cellular (RBP7) -1.61 
 GGA.10858.1.S1_S_AT 
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, 
antitrypsin), member 1 (SERPINA1) 
-2.15 
 GGA.12648.1.S1_AT 
six transmembrane epithelial antigen of the prostate 1 
(STEAP1) 
-1.57 
 GGA.16172.1.S1_S_AT hypothetical gene supported by CR385555 -1.91 
 GGA.16552.2.S1_A_AT hypothetical gene supported by CR387685 -1.59 
 GGAAFFX.11018.1.S1_S_AT matrix metallopeptidase 1 (interstitial collagenase) (MMP1) -1.63 
 GGA.10034.2.S1_A_AT 
Serpin peptidase inhibitor, clade B (ovalbumin), member 2 
(SERPINB2) 
-1.54 
 GGA.11602.1.S1_AT transcribed locus -1.54 
 GGA.16043.1.S1_S_AT CSRP2 binding protein (CSRP2BP) -1.58 
 GGA.1725.2.S1_A_AT finished cdna, clone chest592m12 -1.58 
 GGA.17737.1.S1_AT finished cdna, clone chest1025a6 -1.66 
 GGA.19101.1.S1_AT finished cdna, clone chest926n8 -1.69 
 GGA.19476.1.S1_AT finished cdna, clone chest883k3 -1.62 
 GGA.2890.1.S1_AT finished cdna, clone chest1021c11 -2.18 
 GGA.6292.1.S1_A_AT transmembrane 4 L six family member 4 (TM4SF4) -1.81 
 GGA.6666.1.S1_AT similar to serine protease inhibitor Kazal type 9 -1.63 
 GGA.8082.1.S1_AT RNA binding motif protein 45 (RBM45) -1.51 
 GGA.8540.1.S1_AT finished cdna, clone chest879k19 -1.68 
 GGAAFFX.9703.1.S1_AT hypothetical protein LOC770012 -1.54 
    
Unknown GGAAFFX.1602.1.A1_X_AT  -1.51 
 GGA.9024.1.S1_AT chromosome 8 open reading frame 22 -1.51 
４６ 
 
Figure 14  Relative mRNA levels of B-LB1, BF-2, IRF-1, IRF-7, TNFSF 15 and TLR3 in the 
ilea of chicks fed control diet (open bars) or supplemented with 0.1% MCM-B2 
(shaded bars) for 28 days. Bars represent means ± SEM of n = 6 animals. *, P < 0.05. 
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Chapter Ⅳ 
β1,4 mannobiose (MNB) enhances Salmonella-killing activity and activates 
innate immune responses in chicken macrophages 
 
Introduction 
Salmonella enteritidis (SE) is a foodborne-illness pathogen that 
negatively affects both animal and human health. SE can infect poultry, and is 
one of the most common causes of food poisoning in the United States. Bans or 
reductions in antibiotic use have necessitated the identification of novel 
compounds for the control of SE (Malek et al., 2004). Recent trends in food 
animal health research suggest an increased awareness and need of ‘natural’ 
dietary additives versus chemicals or antibiotics for the purpose of improving 
animal health and performance (Al-Batshan et al., 2001). Food-derived 
compounds that can stimulate or enhance innate immune responses to 
pathogens are therefore an attractive alternative to antibiotics. 
Macrophages are a central arm of the innate immune defense system 
against intracellular pathogens. Stimulated macrophages undergo a process of 
activation involving an increase in size and motility, enhanced phagocytic 
potential, bactericidal, and tumoricidal activity (Bliss et al., 2005). Among the 
antimicrobial mechanisms associated with macrophages, the generation of 
reactive oxygen species (ROS) and reactive nitrogen species (RNS), such as 
H2O2 and NO, plays a major role in intracellular bacterial killing (Lim et al., 
2004). Despite this array of antimicrobial activity of macrophages, some 
intracellular bacteria, including Salmonella, Leishmania and Mycobacteria, are 
able to survive within the phagosome. Activated macrophages, therefore, 
depend on a complex array of oxygen-dependent antimicrobial molecules to 
inhibit or kill intracellular Salmonella. An early phase of Salmonella killing is 
mediated through contribution of the NADPH phagocyte oxidase (phox, NOX-1) 
and subsequent sustained bacteriostatic effect, which is dependent on inducible 
nitric oxide synthase (iNOS), responsible for the production of NO 
(Vazquez-Torres et al., 1999). In mice, a single dominant gene termed natural 
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resistance associated macrophage protein 1 (NRAMP1) controls innate 
resistance to such pathogens (Alter-Koltunoff et al., 2008). The NRAMP1 gene 
is exclusively expressed in monocytes/macrophages and its importance in 
killing the intraphagosomal pathogens was reported both in vitro and in vivo 
(Vidal et al., 1993; White et al., 2005).  
Prebiotics, including mannan oligosaccharides (MOS), one of the most 
popular commercially available prebiotics for poultry use (Ferket, 2004), have 
shown considerable promise for modulating innate immune responses in the 
gut and preventing bacterial infection. We previously demonstrated that MCM 
including MNB could act as an immunomdulatory agent in vivo, preventing SE 
infection in broilers by increasing IgA production and improving SE clearance 
(Agunos et al., 2007). The objectives of the present study were to examine the in 
vitro innate immunomodulating effects of MNB using the chicken macrophage 
cell line MQ-NCSU. MNB-induced phagocytic and Salmonella-killing activity, 
production of antimicrobial effectors, and expression of key genes involved in 
antimicrobial and innate host defense mechanisms were examined in order to 
elucidate the mechanism of MNB-mediated Salmonella prevention in vivo. 
 
 Materials and Methods  
 Preparation of MNB  
Crude MNB was prepared from Philippine coconut flour. Coconut flour 
was defatted with 2 g/g hexane, and then suspended in 10 mL/g distilled water 
at 80°C for 2 hrs. The solid was collected by centrifugation at 10,000 × g for 20 
min, then suspended in 10 mL/g distilled water at room temperature for 10 min, 
and again collected by centrifugation. These steps were repeated, and the solid 
was hydrolyzed with β-mannanase (Shin-Nihon Chemical Co Ltd., Aichi, 
Japan).  Following centrifugation at 10,000 × g for 20 min, the supernatant 
was lyophilized and dissolved in deionized water at 20% (w/v). This crude 
sample was used for further purification. To obtain highly purified MNB, 5 ml 
of 20% (w/v) crude MNB solution was applied to a Bio-Gel P2 fine gel filtration 
column (25 Φ × 1 m; Bio-Rad Laboratories, Hercules CA, USA). The sample was 
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eluted with distilled water at 0.5 ml/min, and 4-ml fractions were collected. 
Saccharide concentrations were measured by the phenol-sulfuric acid method 
(Dubois et al., 1956) and mannobiose-containing fractions were combined and 
lyophilized. According to this method, 99% pure MNB was obtained and its 
purity and structure were confirmed by HPLC, MADLI-TOF-MS and NMR 
spectroscopy (data not shown). 
 
Cells and culture conditions 
MQ-NCSU cells, a macrophage-like cell line originally derived from 
spleen cells of leghorn pullets challenged with the JM/102W strain of Marek’s 
disease virus (Qureshi et al., 1990), were a gift from North Carolina State 
University. Cells were cultured as described previously by Kramer et al. 
(2003b). Briefly, cells were grown in RPMI 1640 medium (Invitrogen Corp., 
Carlsbad, CA) supplemented with 5% tryptose phosphate broth (Sigma-Aldrich, 
St. Louis, MO), 8% FBS (PAA Laboratories Inc., Etobicoke, ON), 10% chicken 
serum (Sigma-Aldrich), 50 IU/ml penicillin, 50 μg/ml penicillin-streptomycin 
(Invitrogen Corp.), and 5 x 10-5 M 2-mercaptoethanol (Sigma-Aldrich) at 41°C 
in a 5% humidified CO2 incubator.  
Salmonella enterica serotype Enteritidis PT4 was inoculated into Brain 
Heart Infusion (BHI) broth (DIFCO/Beckton Dickinson, Sparks, MD) and 
grown overnight at 37°C with shaking. Overnight cultures were then diluted in 
RPMI 1640 medium and incubated for 3 hrs, to yield approximately 1 x 108 
colony forming units (CFU)/ml. Total yield was confirmed by plating and colony 
counting on Brilliant Green Agar (BGA) (DIFCO/Beckton Dickinson). 
 
Phagocytosis assay 
Phagocytosis assays were carried out using a Vybrant™ Phagocytosis 
Assay Kit according to the manufacturer’s instructions (Molecular Probes Inc., 
Eugene, OR). Briefly, MQ-NCSU cells were seeded at a density of 1 x 105 
cells/well in 96-well black polystyrene plates (Corning Inc., Corning, NY), and 
allowed to adhere for 1 hr. MNB was added at the indicated concentrations, and 
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baseline levels of uptake were measured using untreated cells. Cells were also 
stimulated with SE LPS (0.5 μg/mL) (Sigma-Aldrich) as a positive control. 
Culture medium was removed and fluorescein-labeled E. coli BioParticles® 
(Molecular Probes) were added. Cells were incubated for 2 hrs, following which 
medium and BioParticles were removed and 200 μL/well of trypan blue solution 
(1.25 mg/mL) was added. After 10 min at 41°C the trypan blue solution was 
removed and the plate was read in a fluorescence plate reader using 480 nm 
excitation and 520 nm emission. Results are expressed as percent phagocytosis 
relative to untreated cells. 
 
Salmonella-killing activity of chicken macrophages 
The effect of MNB on Salmonella-killing activity was measured using a 
viable count assay of SE in macrophages stimulated with MNB, modified from 
protocols described by Kramer et al. (2003b) and Chadfield and Hinton (2004). 
MQ-NCSU cells were seeded at 5 x 105 cells/well in 24-well culture plates 
(Corning Inc.) and treated for 2 hrs with MNB at the indicated concentrations. 
Medium was removed and SE was added at a multiplicity of infection (MOI) of 
100, and incubated for 30 min at 37°C to allow bacterial adhesion and 
colonization. Gentamicin (100 μg/mL) (Life Technologies Corp., Carlsbad, CA, 
USA) was then added to kill extracellular SE. Cells were washed twice with 
PBS containing 5% FBS, and 1 mL/well of RPMI 1640 supplemented with 10% 
FBS, 10% chicken serum and 10 μg/mL gentamicin was added to prevent 
re-infection with SE and to prevent growth of SE in the medium derived from 
the release of SE from dead cells. The number of intracellular bacteria at 
indicated time points post infection was determined by lysing cells with 1 mL of 
PBS containing 0.2% (w/v) saponin (Sigma-Aldrich) or 200 μg of 0.1% Triton 
X-100 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) and then plating 
10-fold dilutions on BGA in order to enumerate viable SE.  
 
 
 
５１ 
Quantification of nitrite production  
Nitrite production, an indicator of NO synthesis, was measured in the 
culture supernatant as previously described by Kleinerman et al. (1987) with 
modifications. Cells were seeded at 1 x 105 cells/well in 96-well tissue culture 
plates (Corning Inc.) and cultured in the presence of MNB for 48 hrs at the 
indicated concentrations. Culture medium alone was used as control. After 48 
hrs, 100 μL of Griess reagent (1% sulphanilamide and 0.1% 
naphthylenediamide in 5% phosphoric acid) (Sigma-Aldrich) was added to 100 
μL of culture supernatant and absorbance at 570 nm was measured using a 
microplate reader. Nitrite concentrations were determined from a standard 
curve of sodium nitrite (Sigma-Aldrich) in culture medium. 
 
Quantification of H2O2 production 
H2O2 production was measured using an Amplex® Red Hydrogen Peroxide 
Kit (Molecular probes, Eugene, OR, USA). Cells were seeded at 1 x 105 
cells/well in 96-well tissue culture plates and cultured in the presence of MNB 
for 24 hrs at the indicated concentrations. Culture medium alone was used as 
control. After 24 hrs, the culture medium was aspirated and cells were washed 
with cold PBS. 100 μL of Amplex Red working reagent (50 μM Amplex Red and 
0.1 U/ml HRP) in Krebs-Ringer phosphate buffer (KRPG, 145mM NaCl, 5.7 
mM sodium phosphate, 4.86 mM KCl, 0.54 mM CaCl, 1.22mM MgSO4, 5.5 mM 
glucose, pH 7.35) was added to the cells and absorbance at 570 nm was 
measured using a microplate reader. H2O2 concentrations were determined 
from a standard curve of H2O2 in KRPG. 
 
RNA extraction and real-time RT-PCR 
The effect of MNB on gene expression was examined by real time 
quantitative PCR. MQ-NCSU cells were seeded at 2.5 x 105 cells/well in 24-well 
plates and incubated with 40 μg/mL MNB in a total volume of 0.5 mL medium 
for 16 hrs at 41°C. Total RNA was extracted from the cells using the Aurum™ 
Total RNA Mini Kit (Bio-Rad Laboratories) according to the manufacturer’s 
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instructions. The quantity and quality of the RNA was verified by 
spectrophotometry and gel electrophoresis. First-strand cDNA synthesis was 
carried out using the iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Inc.) 
according to the manufacturer’s instructions, and 100 ng cDNA was used for 
each real-time PCR reaction. Real-time PCR was carried out using iQ™ SYBR 
Green Supermix (Bio-Rad Laboratories, Inc.) on a MyiQ™ Single Color 
Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.) using the 
following conditions: denaturation 15 s at 95°C, annealing 15 s at 56 °C, and 
extension 30 s at 72 °C. Chicken primers were designed using Primer3 v.0.4.0 
(Rozen and Skaletsky, 2000) and synthesized by the University of Guelph 
Laboratory Services Molecular Biology Section (Guelph, ON), and were used at 
a final concentration of 400 nM per reaction. The primers used were as follows: 
GAPDH, 5’- CAA CAT CAA ATG GGC AGA TG-3’ and 5’-AGC TGA GGG AGC 
TGA GAT GA-3’ (NM_204305); iNOS, 5’- GGC TGT GCT TCA TAG CTT CC-3’ 
and 5’- TAT GCT CCC CGA CAT AGG AG’3’ (NM_204961); NOX 1, 5’- CAT GGT 
CAC ATC CTC CAC TG-3’ and 5’- CACCTCCTTCATGCTCTCCT-3’ 
(NM_001101830); NRAMP, 5’- CTG CAC TCC TCA TTG GTG AA-3’ and 5’- GCC 
ATG ACG AAG AGG TTG AT-3’ (NM_204964); LITAF, 5’- TTC AGA TGA GTT 
GCC CTT CC-3’ and 5’- TCA GAG CAT CAA CGC AAA AG-3’ (NM_204267); 
IFN-γ, 5’-GGC GTG AAG AAG GTG AAA GA-3’ and 5’-TCC TTT TGA AAC TCG 
GAG GA-3’ (NM_205149). Relative gene expression was calculated by 2-ΔΔCt 
method using GAPDH as internal control, and results were expressed as fold 
change relative to untreated (control) cells. 
 
Statistical analysis 
Statistical analysis was carried out using GraphPad Prism version 5.00 
for Windows (GraphPad Software, San Diego, CA). Comparisons between 
treatment groups were performed with one-way analysis of variance (ANOVA) 
followed by the Tukey-Kramer multiple comparison test. Results are presented 
as mean values  SEM of three independent experiments. Results were 
considered significant if P < 0.05. 
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Results and discussion 
Examination of the phagocytic response of MQ-NCSU cells in the presence 
of MNB revealed that pre-treatment of the cells with MNB significantly 
increased phagocytosis (P < 0.05) when compared to cells alone, to levels 
similar to that elicited by LPS (Figure. 1). A >2-fold phagocytic increase was 
observed in cells treated with MNB when compared to untreated cells. The 
improvement in such non-specific phagocytosis not only has implications for 
Salmonella pathogenesis, but also suggests that in vivo, macrophages may be 
better able to trap foreign antigens and initiate the adaptive phase of the 
immune response by antigen processing and presentation (Lim et al., 2004).  
 
Figure 15   Effect of MNB on phagocytic activity of chicken macrophages. MQ-NCSU cells 
were treated with increasing concentrations of MNB for 2hrs, followed by 
incubation with fluorescein-labeled E. coli BioParticles. Data shown are mean ± 
SEM. Results are expressed as % phagocytosis relative to untreated cells. *P < 
0.05 compared to untreated cells. 
 
MNB time- and dose-dependently increased the Salmonella-killing 
activity of macrophages, with the most marked reduction in SE viability seen at 
40 μg/mL after 48 hrs (Table 10), where a >2-fold reduction in log CFU values 
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was observed when compared to untreated control cells infected with SE, which 
has previously shown to be highly invasive and capable of survival within 
MQ-NCSU cells (Withanage et al., 2005).    
 
Table 10  Effect of MNB treatment on Salmonella-killing activity of chicken macrophage cells. 
Values represent changes in mean CFU (log10) of S. enteritidis PT4 during 
phagocytosis with MQ-NCSU cells after pretreatment with MNB (±SEM, n=3). 
 Treatment 
Time 
(hr) 
  MNB (μg/mL) 
Controla Controlb 1 5 10 20 40 
1 7.80 7.79 7.88 7.95 7.71 7.89 7.66 
4 7.48 ± 0.04 7.65 ± 0.29 
7.48 ± 
0.14 
6.88 ± 
0.17 
6.10 ± 
0.32 
6.06 ± 
0.22 
6.10 ± 
0.30 
12 7.56 ± 0.06 6.95 ± 0.18 
7.48 ± 
0.07 
6.11 ± 
0.07 
6.06 ± 
0.17 
4.78 ± 
0.11 
4.85 ± 
0.29 
24 7.61 ± 0.12 6.12 ± 0.19 
6.44 ± 
0.11 
5.78 ± 
0.16 
5.14 ± 
0.09 
4.11 ± 
0.29 
3.69 ± 
0.16 
48 7.45 ± 0.07 6.05 ± 0.12 
6.10 ± 
0.15 
5.28 ± 
0.14 
4.35 ± 
0.05 
3.78 ± 
0.33 
3.33 ± 
0.19 
aSE alone 
bMQ-NCSU cells infected with SE, no MNB added 
 
Macrophages exert their potent antimicrobial effects by the release of a 
number of cytotoxic/cytostatic factors such as reactive oxygen species (ROS), 
such as H2O2 and superoxide, as well as reactive nitrogen species (RNS) and 
other enzymes and chemical mediators which can result in the destruction of 
intracellular pathogens (Lim et al., 2004). The importance of both oxidative and 
nitrosative responses in the clearance of Salmonella infection is well known, 
and has been demonstrated in vivo, where mice deficient in both NADPH 
phagocyte oxidase (NOX-1) and inducible nitric oxide (NO) synthase (iNOS) 
were unable to clear infection with Salmonella (Mastroeni et al., 2000). 
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Furthermore, the reaction of RNS with ROS generates peroxynitrite, a reactive 
molecule with potent antimicrobial activity against S. typhimurium in vitro 
(Nathan and Shiloh, 2000). As would be expected, MNB-induced 
Salmonella-killing activity correlated with increases in both nitrite and H2O2 
production by MQ-NCSU cells. MNB treatment dose-dependently increased 
both H2O2 (Figure. 16A) and nitrite (Figure. 16B) production. When compared 
to untreated cells, MNB-induced H2O2 production was significantly higher (P < 
0.05) at doses greater than 10 μg/mL, (resulting in 17-fold to 33-fold increases 
in H2O2 production). MNB-induced nitrite production was also significantly 
higher when compared to untreated cells, at all doses tested (P < 0.05 for 10 
and 20 μg/mL; P < 0.001 for 30 and 40 μg/mL), resulting in a >4-fold increase in 
NO production when compared to untreated cells.  
In order to further examine the innate immune-modulating effects of 
MNB on macrophages, MQ-NCSU cells were treated with MNB and the 
expression of several genes involved in innate immunity and antibacterial 
activity were measured. MNB-treatment significantly increased expression of 
iNOS (P < 0.01), NOX-1 (P < 0.05), LITAF (P < 0.05), NRAMP1 (P < 0.05), and 
IFN-γ (P < 0.05) when compared to untreated cells (Figure 17). MNB-induced 
gene expression was equivalent to, if not higher than, that induced by LPS, 
indicating that like LPS, MNB may be capable of stimulating early response of 
macrophages to bacterial infection.  
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Figure 16   Effect of MNB on H2O2 (A) and NO (B) production in chicken macrophages. 
MQ-NCSU cells were treated with increasing concentrations of MNB for 24 
(H2O2) or 48 (NO) hrs. Data shown are mean ± SEM of three independent 
experiments. *P < 0.05, ***P < 0.001 compared to untreated cells. 
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Figure 17   Effect of MNB on gene expression of iNOS, NOX-1, LITAF, NRAMP1, and INF-γ in 
chicken macrophages. MQ-NCSU cells were treated with 40 μg/mL MNB for 16 
hrs, and total RNA was isolated and gene expression analyzed by real-time 
RT-PCR. Results are expressed as fold change relative to untreated (control) cells. 
*P < 0.05. 
 
Both NOX-1 and iNOS have been found to be required for effective host 
resistance against Salmonella in vivo in mice (Rosenberger and Finlay, 2002) 
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and mRNA expression of both of these genes was significantly increased 
following MNB treatment when compared to cells alone. NOX-1 activity 
produces superoxide that can lead to the generation of other toxic reactive 
oxygen intermediates, such as H2O2, which can directly cause oxidative damage 
to bacteria (Rosenberger and Finlay, 2002). NADPH oxidase has been shown to 
mediate iNOS expression in mouse macrophages (Lanone et al., 2005), which 
leads to the enhanced production of reactive oxygen species (Zhao et al., 2010), 
and indeed we observed a concomitant increase in the expression of both NOX-1 
and iNOS in MNB-treated cells  
Interferon (IFN)-γ plays an important role in the early phase of resistance 
during bacterial infection, and Nauciel and Espinasse-Maes (1992) (Nauciel 
and Espinasse-Maes, 1992) found that ablation of IFN-γ by administration of 
anti-IFN-γ antibodies enhanced bacterial proliferation and death in mice 
infected with a sub lethal dose of S. typhimurium. IFN-γ stimulation 
up-regulates the expression of many antimicrobial effectors and impairs 
replication of S. typhimurium within macrophages (Gulig et al., 1997), and 
IFN-γ-activated macrophages display enhanced microbicidal activities upon 
bacterial expression, due to changes in the expression of genes such as iNOS 
(Held et al., 1999). It has been suggested that priming cells with IFN-γ may 
enable the host to respond quickly to relatively low doses of LPS, thereby 
activating antibacterial defenses (Held et al., 1999). Here, MNB treatment 
increased IFN-γ, and therefore may have provided the necessary first signal to 
enable enhanced killing of SE. 
Resistance to intracellular pathogens such as Salmonella, is also strongly 
influenced by the expression of NRAMP1 (Fritsche et al., 2008), which may act 
by modulating iron transport, limiting its availability to intracellular 
microorganisms (Biggs et al., 2001; Mulero et al., 2002; Schaible and Kaufmann, 
2004) and effecting macrophage immune function, since iron decreases the 
activity of IFN-γ-mediated antimicrobial pathways, including the formation of 
NO (Fritsche et al., 2008). NRAMP-1 functionality increases NO formation 
(Fritsche et al., 2003), the importance of which has been illustrated by the 
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observation that mice lacking iNOS are rendered susceptible to Leishmania 
infection (Wei et al., 1995), and Govoni et al. (1999) found that expression of 
recombinant NRAMP1 by mouse macrophage (RAW 264.7) cells abrogated 
intracellular replication of S. typhimurium. In addition, iNOS and NRAMP1 
expression have been shown to be associated with responses to SE in vivo, in 
both vaccinated and non-vaccinated chickens (Kramer et al., 2003a; Malek and 
Lamont, 2003). 
Lipopolysaccaride-induced TNF-α factor (LITAF) binds to a critical region 
of the TNF-α promoter and is reported to be involved in activation of TNF-α 
expression during LPS induction (Myokai et al., 1999), however, little is known 
about the function of LITAF in poultry (Malek and Lamont, 2003). LITAF 
expression was found to be up-regulated following in vitro stimulation of 
macrophages with S. typhimurium LPS, as well as after treatment with 
Eimeria, the causative agent of avian coccidiosis (Hong et al., 2006), suggesting 
that it may play a role in bacterial clearance and inflammatory responses, and 
may have been involved in the MNB-induced anti-SE activity observed here.  
These results indicate that MNB can increase the Salmonella-killing 
activity of macrophages, and may act as a potent immunomodulator, via its 
ability to up-regulate the expression genes involved in host-defense and 
stimulate the production of reactive oxygen and nitrogen species. Additional 
study is required to further elucidate the mechanism of action of MNB as well 
as explore additional roles of MNB as an antimicrobial and innate 
immune-enhancing agent. 
This is an Author’s Accepted Manuscript of an article at  : 
http://www.sciencedirect.com/science/article/pii/S0165242710003478. 
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Chapter Ⅴ 
Effect of dietary mannanase-hydrolyzed copra meal (MCM) on growth 
performance and intestinal histology in broiler chickens. 
 
Introduction 
A number of chemical or immune-based approaches, including the use of 
disinfectants, insecticides, vaccines, and antibiotics, have been widely used for 
preventing infections with animal pathogens and for improving meat 
production. However, the continued use of dietary antibiotics has given rise to 
the development of drug-resistant bacteria (Sørum et al., 2001). In addition, 
recent trends in food animal health research has suggested an increased 
awareness and need for ‘natural’ dietary additives versus chemicals or 
antibiotics for the purpose of improving animal health and performance 
(Al-Batshan et al., 2001).  
Food-derived compounds that can stimulate or enhance innate immune 
responses to pathogens are therefore an attractive alternative to antibiotics. 
Although the dominant prebiotics are fructooligosaccharide products, 
additional prebiotics, such as trans-galactooligosaccharides, 
glucooligosaccharides, lactose, and sucrose, have been investigated (Collins and 
Gibson, 1999). Moreover, Fritts and Waldroup(2003) and Ferket (2004) have 
reported that mannan oligosaccharides, which are derived from the yeast cell 
wall, might be useful as part of an overall feeding strategy to aid in overcoming 
the potential loss of growth-promoting antibiotics (Fritts and Waldroup, 2003; 
Ferket, 2004). In particular, MCM and its main component, MNB, have been 
reported to improve Salmonella enterica clearance, to reduce the degree of 
intestinal pathology in cecal tonsils, and to increase IgA production and the 
number of intraepithelial mononuclear cells in chicks (Agunos et al., 2007). 
Moreover, in a study of 200,000 commercial broilers, MCM was reported to 
promote growth with increasing IgA production (Fukui et al., 2009).  
Furthermore, in a study using microarray and real-time transcription 
polymerase chain reaction analysis, MCM including MNB was suggested to act 
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as a potent immune-modulator and to exert a combination of effects on the 
intestinal immune system (Ibuki et al., 2010).  
The in vitro immuno-modulating activities and antibacterial effects of 
MNB were also confirmed in chicken macrophages (Ibuki et al., 2011). Based on 
the above studies, We expected that MCM including MNB (or a component 
within it) would have an effect on the immunomodulatory system and thereby 
lead to changes in the intestinal histology. If so, MCM including MNB could 
improve growth performance in broiler chickens. However, the data on the 
relationship between growth performance and the effects of MCM 
administration on the small intestinal tissues in chickens are currently 
insufficient. Therefore, the purpose of this chapter was to observe the effects of 
MCM including MNB on growth performance and intestinal histology in broiler 
chickens. 
 
Materials and Methods 
Source of feed additives  
MCM including MNB was provided by Fuji Oil, Ltd. (Osaka, Japan) and 
contained 11.4% MNB (MCM-B1). The different MCM-B1 components are 
shown in Table 11. 
Table 11  MCM-B1 components 
General composition (%) Crude protein* 23.0 
 Crude fat 8.2 
 Ash 6.0 
 Moisture 5.0 
  Carbohydrate 57.8 
Free sugar contents (%) Glucose 1.6  
 Mannose 2.4  
 Fructose 1.9  
 Sucrose 4.5  
  Mannobiose 11.4  
* Kjeldahl method: N*6.25   
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Experimental diet 
The conventional mash diets (Nichiwa Sangyo Co. Ltd., Kagawa, Japan) 
were provided as the basal diet. The experimental diets were supplemented 
with 0.1% and 0.02% MCM-B1. The starter or grower crumble was without 
antibiotics or anticoccidial drugs (Table 12). The dose of MCM-B1 was based on 
the previously reported supplementation of chicks with 0.1% MCM-B1 in feed 
(Agunos et al., 2007; Fukui et al, 2009). 
 
Feeding experiments 
All experiments were performed according to the humane care guidelines 
for the use of animals for experimentation as provided by Kagawa University in 
Japan (Kagawa University, 2006). Forty-eight male Marshall Chunky broilers 
that were 1 day in age were fed for 7 days. Afterwards, the birds were divided 
into 3 groups with 4 replicates of 3 birds with an equal mean body weight.  
The birds were housed in wire pens under a dairy lighting regimen of 13-h 
light and an environmental room temperature. The broilers were fed with 
experimental starter and finisher diets from 7–21 days of age and from 22–49 
days of age, respectively. The birds were allowed feed and water ad libitum 
throughout the feeding periods. Feed consumption and body weight were 
recorded weekly. 
 
Tissue sampling 
At the end of the feeding experiment, 4 birds from each group were 
weighed and killed by decapitation under light anesthesia with diethyl ether. 
The entire small intestine was quickly excised and placed in a fixative of 3% 
glutaraldehyde and 4% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4). 
The intestinal segment from the gizzard to the pancreatic and bile ducts was 
regarded as the duodenum; from the ducts to Meckel’s diverticulum, as the 
jejunum; and from the diverticulum to the ileo-cecal-colonic junction, as the 
ileum. The same fixative solution was injected into each section of the 
intestinal lumen, and the middle portion of each section was used for 
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observation. 
 
Table 12  Feed formulation and nutrient composition of the commercial broiler starter diet and 
the finisher mash diet 
 Starter   Finisher 
 (days 1–21)  (days 22–49) 
Ingredients (%)    
Ground maize 51.00   58.00  
Milo 2.00   9.00  
Soybean meal 37.00   22.00  
Fish meal 4.00   4.00  
Animal fat 4.00   4.60  
Rapeseed meal -  0.60  
Calcium carbonate 1.00   0.85  
Calcium phosphate tribasic 0.70   0.65  
Sodium chloride 0.15   0.15  
Vitamin/mineral premix * 0.15   0.15  
    
Calculated component    
Crude protein 23.50   18.00  
Metabolisable energy (kcal kg-1) 3100.00   3200.00  
Crude fibre 4.00   4.00  
Crude fat 4.50   6.00  
Calcium 0.80   0.70  
Phosphorus 0.60    0.55  
*Concentrate mixture of the diet (per kg of diet): vitamin A, 10,800 IU; vitamin D3, 
2,000 IU; vitamin E, 25 mg; vitamin K3, 2 mg; vitamin B1, 5.4 mg; vitamin B2, 7.2 
mg; vitamin B6, 10.2 mg; vitamin B12, 8 mg; biotin, 0.3 mg; folic acid, 1.1 mg; 
pantothenic acid, 17 mg; nicotinic acid, 70.2 mg; choline, 1,500 g; zinc, 80 mg; 
copper, 16 mg 
 
Light microscopy 
The segments were cut transversely ~2 cm from the duodenum, jejunum, 
and ileum, fixed in Bouin’s fixative solution at room temperature, embedded in 
paraplast, and sectioned at a thickness of 4 μm. Every tenth section was 
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collected and stained with hematoxylin-eosin.  
Four different parameters (villous area, villous height, epithelial cell area, 
and mitotic cell number) were examined by light microscopy (Nikon Cosmozone 
1S, Nikon Co., Tokyo, Japan) and measured for each intestinal segment using 
an image analyzer (Nikon Cosmozone 1S, Nikon Co., Tokyo, Japan). 
For the measurement of the villi, the villi with lamina propria were 
chosen for analysis. The mean villus height in each bird was based on a total of 
4 villi. The villus areas were calculated from the basal width, apical width, and 
villus height, with 4 villus areas determined for each bird. 
For measuring the epithelial cell area, an area of the epithelial cell layer 
was randomly sampled at the middle of the villi, and the number of cell nuclei 
within this layer was counted. The area of the epithelial layer was divided by 
this number to estimate the area per cell. A total of 4 epithelial areas was 
counted for each bird. For measuring the number of mitotic cells in the villus 
crypt, 5 sections were randomly selected per bird; the cells within each section 
were scored as mitotic if the cells had homogenous, basophilic nuclei that 
intensely stained with hematoxylin-eosin. The number of mitotic cells was 
calculated from 5 different sections for each bird, and these 5 values were used 
to calculate a mean cell mitosis for a single bird. Finally, the mean cell mitoses 
from 4 birds were expressed as the mean cell mitosis for each individual group. 
 
Scanning electron microscopy (SEM) 
Sections (~2 cm in length) of the duodenum, jejunum, and ileum, which 
were close to those used for the light microscopic sample, were slit 
longitudinally. The intestinal contents were washed with 0.1 M phosphate 
buffered saline (pH 7.4). The tissue samples were pinned flat and fixed in this 
flattened position in a 3% glutaraldehyde and 4% paraformaldehyde solution in 
0.1 M cacodylate buffer (pH 7.4) for 1 h at room temperature, cut into 4 mm × 4 
mm squares, and then fixed further for 1 h. The pieces were rinsed with 0.1 M 
sodium cacodylate buffer and were post-fixed with 1% osmium tetroxide in 0.1 
M ice-cold sodium cacodylate buffer for 2 h.  
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The specimens were dried in a critical point drying apparatus. The dried 
specimens were coated with platinum and observed at 8 kV with SEM (Hitachi 
S4300SE/N, Hitachi Ltd., Tokyo, Japan). 
 
Statistical analyzes 
The results were reported as means ± SE. All data were statistically 
analyzed by one-way analysis of variance (ANOVA). Subsequently, data 
statistically significant different at P < 0.05 due to treatments were separated 
by Duncan’s multiple range test. Correlations between the dose of MCM-B and 
each parameter were also calculated using Spearman’s correlation test. All 
statistical analyzes were performed by the Statistical Analysis System (SAS 
Inst. Cary. NY, 2000) and Dr.SPSS-II (SPSS-Inc. Chicago, IL, 2001). 
 
Results 
Growth performance 
The body weight gain and the FE were significantly higher in the 0.1% 
MCM-B1 group relative to that in the control group, while feed intake tended to 
be higher in the 0.02% and 0.1% MCM-B1 groups. For the correlation analysis, 
a significant correlation was observed between the dosage of MCM-B1 and the 
body weight gain and FE (Table 13). 
 
Histological analysis of cellular parameters 
The height and area of the intestinal villi in the experimental groups were 
not significantly different from those in the control group. However, the 
epithelial cellular area of the ileum was significantly higher in the 0.02% and 
0.1% groups compared to that in the control group (P < 0.05). Furthermore, the 
cellular area of the duodenum and the jejunum tended to be higher in the 
0.02% and 0.1% MCM-B1 groups. 
For the correlation analysis, a significant correlation was found between 
the dosage of MCM-B1 and the cell area of the duodenum, jejunum, and ileum. 
Cell mitosis in the duodenum was significantly higher in the 0.1% MCM-B1 
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groups than that in the control group. In terms of the correlation analysis, a 
significant correlation was seen between the dosage of MCM-B1 and cell 
mitosis in the duodenum (Table 13). 
 
 
Table 13  Results of Growth Performance and Intestinal Cellular Histological Parameters  
     Control 0.02% MCM-B1 0.1% MCM-B1 p-value 
Correlation  
coefficients 
Growth performance in broilers fed dietary MCM-B from 7–49 days of age 
 Feed Intake (g) 6097 ± 200 6557 ± 299 6707 ± 310 0.308 0.414 
  Body Weight Gain (g) 2459 ± 110 a 2902 ± 122 ab 3165 ± 205 b 0.027 0.710** 
  Feed Efficiency 0.403 ± 0.013 a 0.444 ± 0.018 ab 0.471 ± 0.013 b 0.031 0.798** 
Intestinal cellular histological parameters measured using light microscopy 
 Villus Height (mm)      
  Duodenum 1.623 ± 0.109 1.859 ± 0.058 1.743 ± 0.095 0.233 0.237 
  Jejunum 1.269 ± 0.109 1.283 ± 0.112 1.366 ± 0.120 0.813 0.207 
   Ileum 0.840 ± 0.061 0.877 ± 0.048 0.889 ± 0.042 0.782 0.118 
 Villus Area (mm2)      
  Duodenum 0.661 ± 0.046 0.748 ± 0.044 0.752 ± 0.043 0.310 0.384 
  Jejunum 0.322 ± 0.038 0.362 ± 0.017 0.458 ± 0.083 0.233 0.384 
   Ileum 0.250 ± 0.026 0.253 ± 0.014 0.240 ± 0.016 0.885 -0.089 
 Epithelial Cell Area (μm2)      
  Duodenum 431 ± 14 480 ± 21 505 ± 21 0.058 0.650* 
  Jejunum 406 ± 12 471 ± 24 467 ± 17 0.057 0.591* 
   Ileum 314 ± 14 a 367 ± 11 b 381 ± 66 b 0.004 0.785** 
 Cell Mitosis (number)      
  Duodenum 1072 ± 41 a 1122 ± 42 ab 1282 ± 66 b 0.041 0.650* 
  Jejunum 908 ± 54 914 ± 8 1032 ± 92 0.323 0.266 
    Ileum 639 ± 42 602 ± 49 527 ± 191 0.792 -0.148 
a, b, values that do not share common letters within a row differ significantly by Duncan's multiple range rage test (P < 0.05).  
*, **, statistically significant correlations were found (P < 0.05 and P < 0.01) 
 
Morphology on the villus tip surface 
Compared to the relatively flat cells of the duodenal villus tip in the 
control (Figure 18-A), those of the 0.02% and 0.1% MCM-B1 treatments were 
６７ 
conspicuously protuberant in appearance (Figure 18-B,C arrow). In addition, as 
shown in Figure 18-C, some of the cells around the central sulcus were devoid 
of any microvilli (arrowhead). The same pattern of cellular features (i.e., flat vs. 
protuberant) in the different treatments was also observed in the jejunal villus 
tip (Figure 19). However, similar to the cells of the ileal villus tip in the control 
group, that of the 0.02%  MCM-B1 treatment group was comparatively flat 
(Figure 20-B). Meanwhile, a clear cell line and more protuberant cells were 
observed in the ileal villus tip in the 0.1% MCM-B1 treatment  
 
Discussion 
In this chapter, we examined the effect of MCM-B1 on growth 
performance and intestinal histology in broiler chickens. The growth 
performance was found to improve with MCM-B1 treatment, and histological 
analysis of the small intestine revealed that dietary supplementation with 
MCM-B1 resulted in an increase in the cell area. A strong relationship between 
mucosal histology and body weight has been previously reported (Awad, et al, 
2006). In particular, an increase in the area of the small intestine results in the 
increased absorption of nutrients (Johnson and Gee, 1986; Awad, et al, 2006; 
Adibmoradi, et al, 2006; Yamauchi, et al, 2006; Samanya and Yamauchi, 2002) 
and thereby contributes to an improved digestion coefficient (Onderci, 2006).  
On the other hand, when the size of the small intestine is reduced, the 
body weight decreases (Batal, et al, 2002), and a decrease in lactase, sucrase, 
and peptidase expression is observed (Hedemann, et al, 2006). Prebiotics, sugar 
cane (Khambualai, et al, 2010), chitosan (Khambualai, et al, 2009), and sesame 
meal (Yamauchi, et al, 2006) have been observed to promote growth through 
changes in villus histological parameters. In this chapter, we also observed that 
the MCM-B1 contribution to growth correlated with increased activation of the 
villus and confirmed that dietary supplementation with MCM-B can increase 
the cell area in the duodenum, jejunum, and ileum.  
In terms of the relationship between intestinal histology and 
immunomodulation, Liu et al. (2008) reported that rabbit sacculus rotundus 
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antimicrobial peptide (RSRP) can increase villus height and the area of 
IgA-secreting cells in each intestinal region, indicating that RSRP can affect 
both Intestinal histology and mucosal immunity. In addition, Bao et al. (2009) 
reported that broilers treated with pig antibacterial peptide had improved body 
weight and average daily gain, greater villus height and gut mucosal thickness, 
increased alkaline phosphatase activity, and a higher ratio of IgA-secreting 
cells when compared to the control group. Lee et al. (2010) reported that 
Bacillus spp., as direct-fed microbials, can affect villus morphology and 
systemic-inflammation immunity. These reports reveal potential relationships 
between immunomodulation and intestinal histology. Further, these findings 
indicate potential relationships between growth promotion, villus morphology, 
and the immunomodulatory system.  
In this chapter, the increased values in the light microscopy parameters 
and the hypertrophied epithelial cells indicate that MCM-B1 could stimulate 
intestinal function, thereby resulting in improved growth performance in 
chickens. These results suggest that MCM-B1 (or a component within it) may 
affect the immunomodulatory system and produce changes in the intestinal 
histology. Thus, MCM-B1 may promote growth performance in broiler chickens. 
However, because an improvement in the intestinal histology and 
immuno-modulation by MNB or MCM-B1 were not observed simultaneously, 
this relationship remains unclear. Research addressing the relationship 
between these effects, including growth promotion by MCM-B, may be the focus 
of a future study. 
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Figure 18 Scanning electron micrographs of epithelial cells on the duodenal(left), jejunal 
(center), and ileal(right) villus apical surface in chickens fed control (A), 0.02% (B), 
and 0.1% (C) MCM-B1 diets.   
Scale bar = 25 µm (×1000). (Arrows = protuberant cells; arrowhead = cell devoid of 
any microvilli; stars = cell clusters) 
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Chapter Ⅵ 
Effect of Dietary β1,4 mannobiose (MNB) on the Growth of Growing Broiler 
Chicks 
 
Introduction 
In-feed antibiotics have been utilized for over half a century to promote 
growth in domestic animals (Moore et al., 1946; Leitnterer et al., 2001; Sun et 
al., 2005). Meanwhile, the extensive use of antibiotics in livestock production 
has increased the risk of development of resistance in human and animal 
pathogens (Bates et al., 1994; Witte, 1998). Thus, the use of antibiotics to 
promote growth in domestic animals has been banned in the European Union 
(Dibner and Richards, 2005). However, the withdrawal of in-feed antibiotics 
suppresses growth in domestic animals, which in turn results in an increase in 
production costs (Casewell et al., 2003; Sun et al., 2005). Therefore, there is a 
pressing need to develop new feed additives that can be used to improve the 
growth of domestic animals. 
Yang et al. (2009), in their review of alternatives to in-feed antibiotics, 
showed the growth-promoting effects of several oligosaccharides in broiler 
chickens. Mannanoligosaccharides have been shown to provide various health 
benefits in broiler chickens. Three major modes of action by which broiler 
performance is improved by Mannanoligosaccharides have been proposed: 1) 
control of pathogenic or potentially pathogenic bacteria which possess type-1 
fimbriae (mannosesensitive lectin), 2) immune modulation, and 3) modulation 
of intestinal morphology and expression of mucin and brush border enzymes 
(Yang et al. 2009). We previously demonstrated that MCM including MNB 
could act as an immune-modulating agent in vivo, preventing SE infection in 
broilers by increasing IgA production and improving SE clearance (Agunos et 
al., 2007), as well as up-regulating the local expression of genes involved in host 
defense and innate immunity (Ibuki et al., 2010). Recently, we also found that 
MNB enhances Salmonella-killing activity, activates innate immune responses 
in chicken macrophages (Ibuki et al., 2011). MCM-B1, which contains 11.4% 
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MNB, was effective for improving intestinal morphology in broiler chickens 
(Ibuki et al, 2013). For example, on the duodenal villus surface of the 0.1% 
MCM-B1-fed chickens, some cells devoid of microvilli were observed, suggesting 
the increased protuberance of these cells represents increased absorption 
activity. In addition, dietary 0.1% MCM-B1 increased body weight gain in 
chickens. These findings raise the hypothesis that MNB can improve growth 
performance in broiler chickens. However, the effects of MNB on growth in 
broiler chickens have not been examined. 
The objective of the present study was to investigate the effects of dietary 
MNB on the growth of growing broiler chicks. 
 
Materials and Methods 
Preparation of MNB 
MNB was prepared from Philippine coconut flour as described previously 
(Ibuki et al., 2011). Coconut flour was defatted with 2 g/g hexane, and then 
suspended in 10 ml/g distilled water at 80°C for 2 h. The solid was collected by 
centrifugation at 10,000×g for 20 min, then suspended in 10 ml/g distilled 
water at room temperature for 10 min, and again collected by centrifugation. 
These steps were repeated, and the solid was hydrolyzed with -mannanase 
(Shin-Nihon Chemical Co. Ltd., Aichi, Japan). Following centrifugation at 
10,000×g for 20 min, the supernatant was lyophilized and dissolved in 
deionized water at 10% (w/v). This crude sample was used for further 
purification. To obtain highly purified MNB, 5ml of 10% (w/v) crude MNB 
solution was applied to a Bio-Gel P2 Fine gel filtration column (ɸ75mm×1m; 
Bio-Rad Laboratories, Hercules CA, USA). The sample was eluted with distilled 
water at 4.5 ml/min, and 25-ml fractions were collected. Saccharide 
concentrations were measured by the phenol-sulfuric acid method (DuBois et 
al., 1956) and MNB-containing fractions were combined and lyophilized. 
According to this method, 99% pure MNB was obtained and its purity and 
structure were confirmed by HPLC. 
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Animals and feed 
Day-old male broiler chicks (chunky) were purchased from a local 
hatchery (Ishii Co. Ltd., Tokushima, Japan). They were given free access to 
water and a commercial chicken starter diet (Nosan Co., Kanagawa, Japan, 
20% of crude protein, 310 kcal of ME/100g diet) and acclimated to the facility 
for 6 days before feeding of experimental diets (Table 14). The dose of MNB 
0.01% was based on our previous report (Agunos et al., 2007; Ibuki et al., 2010). 
Methionine, threonine and arginine were added to diets to meet the 
recommendations of National Research Council for broiler chicks (National 
Research Council, 1994). Chicks were given free access to water and the 
experimental diets throughout the experimental period. All experimental diets 
were provided in powder form. 
A total of 24 eight day-old male broiler chicks were weighed, allocated 
based on the body weight to two cages (1,725 mm x 425 mm x 320 mm, 12 birds 
in each group) and fed a control diet or a MNB diet (Table 1) for 14 days. At the 
end of the experimental period, body weight was measured, and chicks were 
sacrificed by decapitation. This chapter was approved by the Institutional 
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Animal Care and Use Committee (Permission number: 22-05-10) and carried 
out according to the Kobe University Animal Experimentation Regulation. 
 
Sampling and preparation 
Blood was collected from carotid artery. Plasma was separated 
immediately by centrifugation at 3,000 × g for 10 min at 4°C, frozen by liquid 
nitrogen and stored at -80°C for 3-methylhistidine analysis. The liver, 
abdominal adipose tissue, breast muscles and thighs were excised and weighed. 
A portion of the pectoralis major muscle, a major part of breast muscles, was 
frozen immediately for total RNA, protein, and real-time PCR analyzes. 
 
Real-time PCR analysis. 
Total RNA was extracted from the hypothalamus using Sepazol-RNA I 
(Nacalai Tesque, Inc., Kyoto, Japan). First-strand cDNA was synthesized from 
5 μg of DNase I (Ambion Inc., Austin, Texas, USA)-treated total RNA using a 
ReverTra Ace® qPCR RT Kit (TOYOBO CO. LTD., Osaka, Japan) with random 
primers. Complementary DNAs of myostatin, atrogin-1, 20S proteasome 
subunit C1, 20S proteasome C2 subunit, m-calpain large subunit, caspase 3, 
and cathepsin B were amplified with the primers described in Table 15. As an 
internal standard, complementary DNA of ribosomal protein S17 (RPS17) was 
also amplified with the primers described in Table 15. All primers were 
purchased from Hokkaido System Science Co., Ltd. (Sapporo, Hokkaido, Japan). 
THUNDERBIRDTM SYBR® qPCR Mix was purchased from TOYOBO CO. LTD. 
(Osaka, Japan), and mRNA expression was quantified in duplicate using the 
Applied Biosystems 7300 Real-Time PCR system according to the supplier’s 
recommendations. 
 
Plasma 3-methylhistidine analysis. 
Plasma 3-methylhistidine level was measured by the method of Yamaoka 
et al. (2008). 
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Statistical analysis 
Data were analyzed using Student’s t-test. All statistical analyzes were 
performed using the commercial package (StatView version 5, SAS Institute, 
Cary, NC, USA, 1998). 
 
Results 
Table 16  shows the effects of dietary MNB on body weight and several 
tissues in growing broiler chicks. Dietary MNB significantly increased the 
relative weight of breast muscles (P < 0.01). The weight of breast muscles 
tended to increase in the MNB group (P = 0.119). Dietary MNB did not affect 
the weights of the body, thighs, liver, or abdominal adipose tissue. In the 
present study, we did not measure individual feed intake. Therefore, the feed 
intake and feed conversion ratio could not be statistically analyzed. 
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Figure 19 shows the effects of dietary MNB on the plasma 
3-methylhistidine level and breast muscle atrogin-1 mRNA level. Dietary MNB 
did not affect the plasma 3-methylhistidine level or breast muscle atrogin-1 
mRNA level. 
Figure 20 shows the effects of dietary MNB on skeletal muscle protease 
mRNA levels. Dietary MNB did not affect the mRNA levels of any protease. 
Figure 21 shows the effects of dietary MNB on the myostatin mRNA level 
in the breast muscles. The myostatin mRNA level was significantly (P < 0.05) 
decreased by dietary MNB. 
 
 
 
 
 
 
 
Figure 19   Effects of dietary MNB on the plasma 3-methylhistidine concentration and muscle 
atrogin-1 mRNA level in broiler chicks. Data represent the mean ± SEM of 12 birds 
in each group. 
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Figure 20   Effects of dietary MNB on the mRNA levels of proteases in the breast muscles of 
broiler chicks. Data represent the mean ± SEM of 12 birds in each group. 
Figure 21   Effects of dietary MNB on myostatin mRNA level in the breast muscles of broiler 
chicks. Data represent the mean ± SEM of 12 birds in each group. *, Significant 
with respect to the control group (P < 0.05). 
 
Discussion 
In the MNB group, the relative weight of breast muscles was 
significantly increased, but the weight of the thighs was not affected (Table 16). 
The reason for the difference is not clear. One possible explanation is that the 
effect of dietary MNB on the skeletal muscle weight was different between 
muscle fiber types in the chicks. There is evidence that more than 99% of 
muscle fiber in the breast muscle is type II B fiber (Barnard et al., 1982). On 
the other hand, thigh muscles consist of several types of muscle fiber including 
type I, II A, II B, III A, and III B. It is therefore possible that dietary MNB 
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specifically increases type II B fibers in the skeletal muscle in chicks. Further 
studies are required to address this possibility. 
Dietary MNB significantly increased the relative weight of breast muscles, 
whereas the relative weight of abdominal adipose tissue was not affected (Table 
16). In chickens, the percentage of carcass fat is quite consistent with that from 
the abdominal fat adipose tissue (Havenstein, 2003). It is therefore possible 
that MNB specifically increases the breast muscle ratio without affecting body 
fat accumulation in broiler chicks. Further studies are required to address this 
possibility. 
The rate of skeletal muscle growth is altered by the rate of protein 
degradation in skeletal muscle (Goll et al., 2008). Plasma 3-methylhistidine is 
known to be a nonmetabolizable amino acid marker of myofibrillar protein 
catabolism (Hayashi et al., 1985; 1994; Fetterer and Allen, 2000; 2001). 
Therefore, we measured the effects of dietary MNB on plasma 
3-methylhistidine level in growing broiler chicks. However, plasma 
3-methylhistidine was not affected by MNB (Fig. 1). In mammals, mRNA of 
atrogin-1 is markedly induced during muscle atrophy (Dehoux et al., 2004; 
Costelli et al., 2006; Gomes et al., 2001; Bodine et al., 2001). Recently, atrogin-1 
expression under normal conditions has been thought to be related to the rate 
of skeletal muscle proteolysis and muscular size of chickens (Nakashima et al., 
2009, Kamizono et al., 2010). Ohtsuka et al. (2011) showed that atrogin-1 
expression appears to be closely related to the development of skeletal muscle 
proteolysis and skeletal muscle wasting suggesting its usefulness of as a 
reliable index of myofibrillar proteolysis in broiler chicks. However, the 
atrogin-1 mRNA level in the breast muscles was not affected by dietary MNB in 
the presence study (Figure 19). In addition, there was no significant effect on 
the skeletal muscle protease mRNA levels in the breast muscles of broiler 
chicks (Figure 20). All our findings suggest that the increase in the breast 
muscle ratio in the MNB group was not due to the inhibition of skeletal muscle 
proteolysis. 
Myostatin is a negative regulator of myoblast proliferation and 
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differentiation (Otto and Patel, 2010; Elkina et al., 2011). Therefore, we 
analyzed myostatin mRNA level in the breast muscles and found that the 
myostatin mRNA level was significantly (P < 0.05) decreased by MNB (Figure 
21). It is therefore possible that the downregulation of myostatin gene 
expression affected myoblast proliferation or differentiation, which in turn 
resulted in a high breast muscle ratio. Further studies are required to clarify 
this point. 
Recently, a model whereby myostatin induces skeletal muscle wasting 
through targeting sarcomeric proteins via Smad3-mediated up-regulation of 
Atrogin-1 and forkhead box O1 was proposed (Lokireddy et al., 2011). In the 
present study, we found that the myostatin mRNA level was significantly (P < 
0.05) decreased by MNB (Fig. 3, P < 0.05). Dietary MNB did not affect the 
mRNA level of breast muscle atrogin-1. However, the means of atrogin-1 mRNA 
level in the MNB group was about 66.2 % of that in the control levels. It is 
therefore possible that dietary MNB-decreased myostatin mRNA level is 
related to the decrease of atrogin-1 mRNA level in the breast muscle. 
As mentioned in the introduction section, three major modes of action by 
which broiler performance is improved by mannanoligosaccharides have been 
proposed, such as the effects on the undesirable microbiota, immunity, and 
intestinal mucosa (Yang et al. 2009). We recently found that MNB enhances 
Salmonella-killing activity, activates innate immune responses in chicken 
macrophages (Ibuki et al., 2011), and possibly improves intestinal morphology 
in broiler chicks (Ibuki et al., 2013). In the present study, we suggest that 
dietary MNB may induce protein synthesis in breast muscles. Thus, further 
study will be needed to investigate the involvement between the stimulation of 
protein synthesis by MNB and the suppression of pathogenic bacteria or the 
modulation of intestinal morphology or immune responses. 
As observed in other studies showing the effect of feed ingredients on 
growth performance in broiler chicks (Yamamoto et al., 2007; Baurhoo et al., 
2009; Khambualai et al., 2009; Saleh et al., 2011), study with a small number of 
chickens (n = 7 - 12) have been published in several international scientific 
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journals. Therefore, in the present study, 12 birds were assigned in each group. 
However, the number of chickens should be increased in future study. 
In conclusion, we investigated the effects of dietary MNB on the growth of 
broiler chicks. Our results showed that MNB increases the relative weight of 
breast muscles to body weight in growing broiler chicks. These results suggest 
that MNB could be a promising candidate feed additive to improve meat yield 
of broiler chickens. 
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Concluding Remarks 
 
The aim of this study is that the evaluation of  the natural feed 
ingredients MNB and MCM as alternatives of antibiotics or growth promoters 
in poultry industry.  
In Chapter I, The author introduced the background and aim of this 
study. 
In Chapter II, The author showed the effects of MCM-B1-supplemented 
feeds on the kinetics of SE in broilers and the ensuing histopathological 
changes. MCM-B1-supplementation reduced SE organ colonisation, cecal 
carriage and faecal shedding in a time-dependent manner. The high 
concentrations and persistency of the SE-specific IgA response in those birds 
given rations supplemented with MCM-B1 or MAN were associated with a 
decline in SE shedding and cecal carriage in the later stages of infection. 
MCM-B1 was more effective against SE infection than MAN. Histological 
examination of the cecal wall and cecal tonsils at 23d post-infection indicated a 
lesser degree of intestinal pathology. An increased number of intra-epithelial 
mononuclear cells (mature lymphocytes and macrophages) in the lining 
epithelium of birds fed on the diet supplemented with MCM-B1 was 
accompanied by an increased number of lamina propria cells. These results 
indicate that feeding a diet supplemented with MCM-B1 during the first two 
weeks after hatching reduced susceptibility to SE infection. Supplementing the 
diet with MCM-B1 or MAN increased IgA production and improved SE 
clearance by acting as immunomodulatory agents that prevented intestinal 
pathology. Feeding a MCM-B1-supplemented diet to broilers could be used as 
an alternative to antibiotics, because it has no adverse effects on mortality or 
weight gain. 
In Chapter III, The author showed the gut immune-modulating activity of 
MCM-B2 using microarray and real-time RT-PCR. No significant difference in 
BW or organ weights was observed between MCM-B2-treated and untreated 
control birds, and no histological abnormalities were observed in any of the 
tissues examined. The MCM-B2-treated chickens had significantly higher 
levels of fecal IgA over all 4 weeks when compared with control birds. 
Microarray and real-time RT-PCR analysis revealed the upregulation of several 
genes involved in immune responses, including those involved in antigen 
recognition, processing and presentation (MHC class I and II), 
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interferon-related genes, and genes involved in host defense. These results 
provide insight into the mechanism of action of dietary MNB in the intestine 
and confirm that MNB acts as a potent immune-modulating agent, exerting 
combined effects on the intestinal immune system. 
In Chapter IV, The author showed the in vitro immune-modulating effects 
of MNB using chicken macrophage (MQ-MCSU) cells. Treatment of MQ-NCSU 
cells with MNB dose-dependently increased both phagocytic activity and 
Salmonella-killing activity of macrophages, with the highest reduction in SE 
viability observed at a concentration of 40 μg/ml at 48 h post-infection. 
Likewise, both hydrogen peroxide (H2O2) and nitric oxide (NO) production were 
increased in a dose-dependent manner by MNB. Gene expression analysis of 
MNB-treated macrophages revealed significant increases in the expression of 
iNOS, NOX-1, IFN-γ, NRAMP1, and LITAF, genes critical for host defense and 
antimicrobial activity, when compared to untreated cells. This data confirms 
that MNB possesses potent innate immune-modulating activities and can 
up-regulate antibacterial defenses in chicken macrophages. 
In Chapter V, The author showed MCM-B1 for its capacity to improve 
growth performance and activate intestinal villus function. Although feed 
intake was not significantly different among the experimental groups, the body 
weight gain and FE were significantly higher in the 0.1% MCM-B1 group than 
in the control group (P < 0.05), while feed intake tended to be higher in the 
0.02% and 0.1% MCM-B1 groups. The cellular area of the ileum was 
significantly higher in the 0.02% and 0.1% groups in relation to that in the 
control group (P < 0.05). Furthermore, the cellular area of the duodenum and 
the jejunum tended to be higher in the 0.02% and 0.1% MCM-B1 groups. For 
the correlation analysis, a significant correlation was observed between the 
dosage of MCM-B1 and the cell area of the duodenum, jejunum and ileum. 
Moreover, the number of mitotic cells was higher in the 0.1% MCM-B1 group. 
As shown by SEM, the cells at the villi tips were protuberant in appearance in 
the 0.02% and 0.1% MCM-B1 treatments when compared with the relatively 
flat cells of the control. On the duodenal villus surface of the 0.1% MCM-B1 
group, some cells devoid of microvilli were observed, suggesting that the 
increased protuberance of these cells represents increased absorption activity. 
Although intestinal villus height and area did not significantly differ among 
groups, the levels of these parameters tended to increase in the experimental 
groups relative to the control. The present morphological findings reveal that 
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MNB might be effective for activating intestinal absorptive function, and that 
the functional activation promotes the growth of the chickens. 
In Chapter VI, The author showed the effects of dietary MNB (99%MNB) 
on the weights of body, breast muscles, thighs, liver, and abdominal adipose 
tissue in growing broiler chicks to evaluate whether MNB can be used as a feed 
additive for broiler chicks. Dietary MNB significantly increased the relative 
weight of breast muscles, whereas the weights of the body, thighs, liver and 
abdominal adipose tissue were not affected. The myostatin mRNA level in the 
breast muscle was significantly reduced by MNB. Since myostatin is a negative 
regulator of myoblast proliferation and differentiation, it is possible that the 
downregulation of myostatin gene expression is involved in the increased 
breast muscle growth with MNB. The plasma 3-methyl histidine level, which is 
known to be a nonmetabolizable amino acid marker of myofibrillar protein 
catabolism, and the breast muscle atrogin-1 mRNA level, which is involved in 
protein catabolism, were not affected by dietary MNB. In addition, MNB did 
not affect protease mRNA levels in the breast muscles. These results suggest 
that MNB does not affect proteolysis in the breast muscles. 
The author infer that the natural ingredient MCM including MNB, which 
is exported from Japan to worldwide as a feed ingredient , is a promising 
candidate for use as a feed additive to promote growth and prevent in 
Salmonella incident in chickens. The author hopes that MCM including MNB 
will be used as an alternative of antibiotics not only for chickens but also for 
other domestic animals. 
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